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Organic bioelectronics is a growing interdisciplinary research field that seeks to
integrate organic electronic transducers (i.e., electrodes, electrochemical/field
effect transistors) with biological systems (i.e., live cell cultures, biomaterials,
and living organisms) for applications in basic research, medical diagnostics,
and tissue engineering. These transducers can operate by either converting a
biological signal into a measurable electrical signal (as in a biosensor), or con-
versely, by providing an electrical stimulus that affects the behaviour or function
of a biological system. This latter approach is the focus of the work presented
in this dissertation.
First, a simple planar device is described based on thin films of the conduct-
ing polymer poly(3,4-ethylenedioxythiophene) doped with p-toluenesulfonate
(PEDOT:TOS) or poly(styrenesulfonate) (PEDOT:PSS). When a linear potential
gradient is applied to this device for one hour in the presence of cell culture
medium, a gradient in oxidation state is established in the PEDOT:TOS film that
remains after the bias is removed. When cells of different types are cultured on
such surfaces, spatial gradients are established in two types of cell behaviour: 1)
Cell adhesion is modulated, enabling gradients in cell density, and spatial con-
trol over cell adhesion; and 2) Cell motility is modulated, enabling continuum
control over cell migration speed and persistence.
Next, the interface mechanism is investigated by which the electrochemical
oxidation/reduction of PEDOT:TOS thin films enables the observed modula-
tion in cell behaviour. To this end, the important adhesion and signalling pro-
tein fibronectin (Fn) is studied, with regard to how its molecular conformation
is directly altered by the local electrochemical oxidation potential of the under-
lying PEDOT:TOS film. Conformation is assessed via Fo¨rster Resonance Energy
Transfer (FRET) studies, which reveal that a linear electrical potential gradi-
ent establishes a smooth, monotonic gradient in the molecular conformation of
surface-adsorbed Fn. The gradient in conformation varies from compact at the
oxidized end of the film, to extended at the neutral part of the film, to partially-
unfolded at the reduced end of the film. Hence, the device is demonstrated to
enable precise electrical control over the molecular conformation of adsorbed
fibronectin.
This device’s ability to control protein conformation as an isolated parame-
ter is then exploited to enable studies of cell secretory behaviour that are inac-
cessible to traditional “biology-only” experiments. The specific role of protein
conformation (both fibronectin and serum proteins) in modulating the secre-
tion of vascular endothelial growth factor (VEGF) is investigated. In particular,
cells cultured on proteins in an unfolded conformation (the condition found in
the tumour environment) secrete larger quantities of VEGF (with verified pro-
angiogenic properties), implicating the role of altered fibronectin conformation
in tumour angiogenesis.
Finally, a three-dimensional macroporous PEDOT:PSS scaffold is intro-
duced. This scaffold represents an electrically-active, three-dimensional en-
vironment for cell culture, offering tunable pore morphology and mechanical
properties, in addition to the electrochemical tunability of conductivity, surface
energy, and pH demonstrated in the two-dimensional thin-film system. This
platform enables confirmation that the electrically-controllable adhesion and se-
cretion behaviours are recapitulated in three-dimensions, and paves the way to-
ward more complex future studies and applications with greater physiological
relevance.
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1.1 Polymers at the Interface with Biology
Synthetic materials have long been used at the interface with biological systems,
particularly in the context of human care in the form of implants and therapeutic
devices. Some such devices are passive in nature, often providing some form
of structural or mechanical support, such as in the cases of hip implants, bone
plates/screws, dental fillings, and arterial stents. Other devices, meanwhile,
actively interact with their biological surroundings in the human body, such as
in the cases of a pacemaker regulating a fibrillating heart, or a dialysis machine
filtering blood.
In all of these cases, a variety of synthetic materials are used in intimate con-
tact with the body and its tissues, and the characteristics of that materials/tissue
interface govern the behaviour, and the success (or failure) of the device perfor-
mance.
In the realm of “active” devices or “smart” surfaces at the interface with bi-
ology, polymers offer a number of distinct advantages over their metallic and
ceramic counterparts. Some of the most important advantages are: similar
mechanical properties to those of tissues, tremendous opportunities for (bio-
)chemical functionalization, very tunable electronic properties, ease and low
cost of processing, the ability to be naturally biodegraded, and an inherent com-
patibility with large-area and flexible substrates.
These many advantages have already made polymers a very successful class
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of materials for biological applications, and the future potential for polymer-
based systems may only be limited by our progress in the development and
processing of new materials and systems.
1.2 Electronics at the Interface with Biology
Electronic devices that interface with biological systems are increasingly finding
applications in basic research, medical diagnostics, and tissue engineering. This
coupling of biology with electronics can be thought of in two ways, somewhat
crudely as read and write operations with respect to the biological system (Figure
1.1).
In the read approach (facilitated by a generalized biosensor), a biological in-
put is sensed by an electronic element, which converts that input into a measur-
able electrical signal (e.g., current or voltage). That signal can then be analyzed
for its significance (or lack thereof). In the write approach, an electronic element
(i.e., a circuit, an electrode array, a transistor, etc.) can provide an electrical
stimulus that affects the behaviour or function of a biological system. This latter
approach is the focus of the work presented here.
Studying and understanding the bioelectronic interface holds interest not
only from a basic research perspective, but also with an eye toward numer-
ous applications in health care and therapeutics. In the realm of biosensors,
the blood glucose sensor represents the most widely successful example to date
(Figure 1.2). Commercially available and relatively cheap, it is an accurate and
important diagnostic and point-of-care device for diabetic patients throughout
the world. Still, even for the glucose sensor there is room for improvement both
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Figure 1.1: Integrated systems of biomaterials (left) and electronic systems
(right) for bioelectronic applications. Reproduced with permis-
sion from Bioelectronics: From Theory to Applications [1].
in terms of availability and low cost, particularly with regard to wide-spread de-
ployment and use in developing nations, where advancements in personalized
and portable diagnostic devices may have the greatest benefits.
Progress also continues to be made in the design and implementation of
biosensors that target a variety of other important analytes, including urea, lac-
tose, and neurotransmitters such as dopamine and acetylcholine. Further de-
velopment of such devices will serve to improve their detection capabilities and
wide-spread availability at reduced costs, with perhaps the Holy Grail being a
cheap, portable, customizable lab on a chip for multi-analyte sensing.
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Figure 1.2: The blood glucose sensor, arguably the most successful exam-
ple of a biosensor to-date. Reproduced by permission under
the Creative Commons Attribution-Share Alike 3.0 Unported
license.
In the realm of interfacing electronics with living tissue, the pacemaker and
the cochlear implant stand out as examples of mature therapeutic technologies
that can monitor and stimulate electrically-active cells. Strides continue to be
made in the development of ocular implants to provide artificial vision, as well
as prosthetic limbs that interface with the human nervous system—all examples
of bioelectronic devices that can restore lost function for patients and greatly
improve quality of life (Figure 1.3).
Much work remains to be done at the interface between electronics and liv-
ing systems. While many successful examples of bioelectronic devices and sys-
tems exist, the functionality they provide, while impressive, is in many cases far
less complex and complete than their natural analogs found in a healthy human
body. As our materials and methods improve, along with our understanding of
the bioelectronic interface, we will be able to design and implement increas-
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Figure 1.3: Examples of bioelectronic (prosthetic) devices interfacing di-
rectly with the human nervous system. (a) A cochlear implant
is shown at left, and (b) examples of prosthetic limbs are shown
at right. Reproduced by permission under the Creative Com-
mons Attribution-Share Alike 3.0 Unported license.
ingly effective and functional devices to help treat patients, and perhaps, to one
day augment our natural abilities. Indeed, the promise of interfacing our minds
with computer systems in an efficient and useful way is a tantalizing possiblity.
The future for bioelectronics is bright, and we have only begun to scratch
the surface in a field whose boundaries may only be limited by our imagination
and willingness to explore what is possible. While it remains to be seen whether
true brain-computer interfaces or functional cybernetic implants will become
fact or remain as fiction, it seems certain that progress in these directions will
provide an abundance of devices and technologies that will enable us to better
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understand and treat diseases, and improve our capabilities and quality of life.
1.3 Organic Electronics
Materials naturally play a central role in the ongoing efforts to interface biology
with electronics. There are many considerations to make when choosing what
materials to employ, or envisioning what new materials might be needed for
a given application. Bioelectronic devices must combine a mix of conductors,
semiconductors, and insulators, that provide sufficiently high performance for
the task at hand, but that also must be suitable for operation in the (often hostile)
in vivo environment of the human body. On top of this, cost is an important
factor to consider, as it must be for any technology geared toward real-world
application.
Many of these considerations provide the impetus to consider the use of
organic electronics for the active materials in bioelectronic devices. As (con-
ducting) polymers, organic electronic materials offer many benefits over inor-
ganic materials in the context of the biological environment, and also provide
some capabilities that inorganics do not possess. Some of the most important
benefits include: similar mechanical properties to those of tissue, the substan-
tial availability of (bio-)chemical functionalization through various chemistries,
their ease and low cost of processing, and their inherent compatibility with
large-area and flexible substrates. The traditional drawbacks of organics, most
notably their lower performance as compared to silicon-based electronics, are
often not a concern due to the lower performance requirements inherent to bio-
electronics applications.
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In addition, conducting polymers are known to be ”smart materials” whose
properties change upon electrochemical oxidation/reduction, a property that
inorganic materials do not possess. This tunability of properties stems from the
dual ionic and electronic conductivities of organics, which are coupled through
the electronic doping/de-doping that occurs through the uptake or expulsion
of ions. This process makes organics ideal electron-to-ion converters – a key
property for communicating between the world of electronics, where informa-
tion is transmitted via the electron, and the world of biology, where information
is tramsitted via ions and larger molecules.
Many properties of an organic electronic material can be changed via the
electrochemical doping/dedoping process, including: surface energy (and thus,
hydrophilicity/hydrophobicity), local pH and chemistry, mechanical stiffness,
surface roughness, and surface charge. These changes in properties enable or-
ganics to actively interact with living cells.
1.3.1 PEDOT:PSS and PEDOT:TOS
Poly(3,4-ethylenedioxythiophene) (PEDOT) is an intrinsically semiconducting,
conjugated polythiophene, whose conductivity can be made semi-metallic with
the inclusion of an ionic salt which dopes the polymer. The most popu-
lar dopant is poly(styrenesulfonate) (PSS), a polyanion which when added
to PEDOT, forms PEDOT:PSS – a water-soluble, highly-conductive polymer
(1000 S/cm) that is easily solution-processed into thin films with excellent trans-
parency (Figure 1.4) . PEDOT:PSS films have traditionally been used in anti-
static coatings, as well as more recently in a variety of electronic applications,
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Figure 1.4: The chemical structure of poly(3,4-ethylenedioxythiophene)
(PEDOT) and the anionic dopant poly(styrenesulfonate) (PSS),
which comprise PEDOT:PSS.
including: as a hole-injection layer for optoelectronic devices [2], and as the ac-
tive channel material in organic transistors [3, 4].
Although PEDOT:PSS is often described as a water-based solution, strictly
speaking it is not soluble in water but instead forms a dispersion in water of
small PEDOT:PSS gel particles [5]. In an untreated state, the outer surface of
these particles is predominantly composed of the non-conductive PSS dopant
chains, as PSS is truly soluble in water (unlike PEDOT). As a result, films formed
from such a dispersion contain many PSS-rich domains which isolate the con-
ductive PEDOT, and consequently limit the overall conductivity of the film [6].
This effect can be mitigated with the addition of a variety of conductivity en-
hancement agents – most popularly dimethylsulfoxide (DMSO) and ethylene
glycol, but more generally including amides, sulfoxides, glycols, imides, surfac-
tants, and salts. The inclusion of such addiditives can increase the conductivity
of PEDOT:PSS films by several orders of magnitude [7, 8].
An alternative dopant is p-toluenesulfonate (tosylate, TOS), a small molecule
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Figure 1.5: The chemical structure of poly(3,4-ethylenedioxythiophene)
(PEDOT) and the anionic dopant p-toluenesulfonate (tosylate,
TOS), which comprise PEDOT:TOS.
oxidant and anion, that both catalyzes the vapour-phase polymerization reac-
tion of PEDOT, and acts as the electronic dopant in the resulting polymer (Fig-
ure 1.5). As compared to PEDOT:PSS films that do not include any additives,
PEDOT:TOS films offer higher conductivities (100s of S/cm), better stability in
aqueous environments, and the ability to conformally coat structures in a non-
line-of-sight manner (due to the vapour-phase nature of the processing).
All of these factors made PEDOT:TOS a more attractive choice of material
over PEDOT:PSS when this work first began (2007); however, recent advances in
the additives and formulations of the more commercially-popular PEDOT:PSS
have meant that at present (2012), PEDOT:PSS films now routinely offer higher
conductivity and better water stability than their PEDOT:TOS counterparts. As
a result, PEDOT:PSS would seem to be the logical material of choice for any
future work that does not specifically require the benefits of vapour-phase pro-
cessing over solution processing. (For additional notes on this discussion, see
Section B.1).
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1.3.2 PEDOT as an Electrochemically-Active Material
Like all conducting polymers, PEDOT has both electrical conductivity, as well
as ionic conductivity. More importantly, these dual conductivities are coupled
through the electrochemical doping/de-doping process that involves both types
of charge carriers. This makes PEDOT an effective electron-to-ion converter; a
key property that makes it an ideal candidate material to bridge the gap be-
tween the world of electronics, where the charge carrier is the electron, and the
aqueous world of biology, where the charge carrier is the ion.
The coupling of an ionic flux into (or out of) the polymer to its electrical con-
ductivity occurs due to a chemical doping/de-doping process similar in nature
to how a dopant such as PSS or TOS increases the native conductivity of PEDOT.
An anionic dopant such as these will partially (and locally) oxidize the PEDOT
chain, introducing an electronic charge that self-localizes to form a polaron on
the polymer backbone [9]. This polaron is free to move along the conjugated
backbone, acting as an additional charge carrier in the material.
Energetically speaking, the introduction of such polaronic (or bi-polaronic)
charge states introduces mid-bandgap energy states, which at heavier doping
levels broaden into bipolaron bands within the bandgap [10]. These serve to
effectively reduce the bandgap of the organic semiconductor, giving it semi-
metallic conductivity.
Mechanistically, electrochemical oxidation (applying a positive bias to the
polymer relative to an aqueous electrolyte) increases the electrical conductivity,
while electrochemical reduction (applying a negative bias to the polymer relative
to an aqueous electrolyte) decreases the electrical conductivity.
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In addition to electrical conductivity, many other properties of PEDOT
change under the influence of electrochemical oxidation/reduction.
1.3.3 Tunable Material Properties
Conducting polymers are known to be “smart” materials whose properties
can change under electrochemical oxidation/reduction. Some of the these
properties include: electrical conductivity, surface energy (hydrophobicity/hy-
drophilicity), colour/optical density (photochromism), mechanical stiffness,
volume (swelling) surface charge, and pH; many of which could likely affect
the adsorption (and steady-state molecular conformation) of proteins, and sub-
sequently the eventual behaviour of living cells.
For PEDOT:PSS and PEDOT:TOS in particular, electrochemical oxidation (re-
duction) leads to an increase (decrease) in conductivity, a decrease (increase) in
surface pH, and an increase in hydrophilicity (hydrophobicity) [Figure 1.6]. Ad-
ditionally, colour/optical density changes due to the photochromic nature of the
film, with the oxidized film appearing nearly transparent and the reduced film
appearing clear, but with a darker blue/purple hue.
Meanwhile, mechanical stiffness in particular does not change appreciably
under electrochemical oxidation/reduction, as measured by liquid-immersion
atomic force microscopy (AFM) in our experimental system [11]. This is par-
ticularly important for cell studies, as it ensures that conformation is altered
in isolation of stiffness, which has known effects on cell behaviour (adhesion,
motility, etc.).
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Figure 1.6: Water contact angle measurements on oxidized and reduced
PEDOT:PSS surfaces, demonstrating tunability of surface ener-
gy/hydrophilicity.
Additionally, the microscopic structure (of PEDOT:TOS) does not change
substantially with redox state, as shown by in situ grazing incidence x-ray
diffraction [12]. While the crystallinity of the films does change slightly with
redox state, the positions of the alternating PEDOT and TOS layers in the thin
film do not change, indicating that the small tosylate counteranions in PEDOT
are not mobile, and therefore do not leach from the film under an applied bias.
This is particularly important as some anionic dopants used in PEDOT formula-
tions show cytotoxicity (i.e., dodecylbenzenesulfonic acid, DBSA, the monomer
of PSS) [13].
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1.4 Biological Systems and Models
1.4.1 The In Vivo Environment
With an eye toward developing devices that may eventually operate within an
in vivo environment, it is worth mentioning the conditions such a device will en-
counter. The relatively warm (37 ◦C), aqueous (conducting) environment of the
body is not particularly hospitable to electronics, and materials must be cho-
sen accordingly. At a minimum, the in vitro laboratory environment requires
materials that are stable in water for long periods of time (up to weeks, pre-
ferrably longer, if any type of long-term cell study is desired), and certainly
in all cases, materials must not be cytotoxic. Devices designed for use in vivo
will face additional challenges, most notably the foreign-body/inflammatory
immune response of the host organism, which may coat the device with scar
tissue, effectively separating it (electronically) from the target tissue or analyte.
Here, an anti-fouling strategy may need to be considered, in an attempt to mask
the device from detection.
The in vivo environment itself is complex, being composed of different types
of tissues, which are themselves composed of both cells, and the extracellular
matrix (Figure 1.7). Of particular (but sometimes overlooked) importance is the
fact that the in vivo environment is three-dimensional (whereas, in contrast, the
vast majority of in vitro laboratory work is two-dimensional). Landmark stud-
ies have shown that cells often behave very differently in 3D environments as
compared to 2D environments, in many contexts including enhanced biological
activities, narrowed integrin usage, and the composition and function of matrix
adhesions. [14]. This is an important consideration with regard to the assumed
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Figure 1.7: The four main tissue types in the human body. Each tissue
is comprised of unique cell types, as well as proteins, proteo-
glycans, and other molecules that form the extracellular ma-
trix. Adapted with permission from the National Institutes of
Health.
physiological relevance of any findings stemming from 2D cell-culture experi-
ments, and points to the need for improved 3D cell-culture systems.
1.4.2 The Extracellular Matrix
The extracellular matrix (ECM) forms the microenvironment for cells in vivo,
and is comprised of proteins (such as collagen, fibronectin, laminin, etc.), pro-
teoglycans, polysaccharides, and other molecules. The ECM provides mechan-
ical support/anchorage for cells, enables migration, and plays a role in control-
ling cellular signalling, both by directly binding cell receptors, and by releas-
ing soluble factors. Cell-ECM interactions are vital to an incredibly wide range
of processes in healthy and diseased tissues, including growth/development,
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wound healing, and metastasis in the context of cancer.
1.4.3 Proteins at the Cell-Surface Interface
Proteins in the ECM play a prominent role in guiding biological signalling and
function, and it is their (often variable) conformation that governs their mul-
tiple biological functions. Proteins are involved in a multitude of signalling
pathways, both inter- and intra-cellular, and also mediate many other interac-
tions that cells have with their environment. In particular, cells adhere to their
local environment by binding to adhesion proteins that are presented on nearby
surfaces; this is true both in vivo, where cells bind to extracellular matrix pro-
teins such as fibronectin (Fn), collagen, vitronectin, etc., as well as in vitro, where
many of these same proteins must be coated or adsorbed onto surfaces of inter-
est. Without the presence of these proteins, cells have no mechanism by which
they can adhere to external surfaces.
1.4.4 Fibronectin
Fibronectin (Fn) is a prominent extracellular matrix glycoprotein that plays im-
portant roles in mediating cell adhesion [15], migration [16], differentiation [17],
and growth [18], during processes such as embryonic development and tissue
remodelling. It is a dimeric molecule with a relatively high molecular weight of
440kDa, and can exist both as a soluble protein, as well as an insoluble compo-
nent of Fn fibers that are prevalent in the extracellular matrix. Fn plays impor-
tant roles in adhesion and signalling events, and binds to cells via membrane-
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spanning receptors called integrins. Fn also binds to other extracellular matrix
components such as collagen, fibrin, etc., and plays an important in processes
such as collagen fibrillogenesis.
Fn is the most abundant adhesion protein present in the serum (Fetal Bovine
Serum, FBS) added to cell culture media, and additionally has previously been
studied and developed for conformation-dependent imaging techniques [19].
For these reasons, Fn was selected as the candidate adhesion protein for further
study.
1.4.5 Structure and Conformations
Fibronectin is a 440kDa protein dimer [20] composed of two similar or identi-
cal monomer subunits of molecular weight 220(20)kDa each, covalently linked
together by disulfide bonds at their carboxy-terimini [21]. Each monomer is
composed of three types of repeating subunits (named type I, II, and III) [20], as
shown in Figure 1.8.
Of particular interest are the III9 and III10 modules, which play important
roles in cell integrin binding (see Section 1.4.7).
Like virtually all large protein molecules, fibronectin exists in a non-
equilibrium state, and can vary substantially in shape (and therefore effective
size), depending on its local environment. The molecular conformation of Fn
can vary reversibly between the extremes of a compact state (globular, as in so-
lution), to a state of partial unfolding, where subunits can become (reversibly)
unfolded. It is this unfolding of the protein’s tertiary structure that lends Fn
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Figure 1.8: The modular structure of a single Fn monomer, composed of
type I, II, and III repeating subunits. Of particular interest are
the III9 and III10 domains, which play important roles in bind-
ing cell integrins. Reproduced by permission under the Cre-
ative Commons Attribution-Share Alike 3.0 Unported license.
its tremendous extensibility, allowing Fn fibers to be reversibly strained by as
much as 700% [22].
Electron microscopy studies have shown the contour length of the most ex-
tended Fn dimers to be 160nm, with an average strand diameter of 2nm [23].
Conversely, Fn can exist in a compact globular form in solution, with a variable
Stokes (hydrodynamic) radius RH ranging from 9.6nm to 14.5nm, depending
on the ionic strength of the solvent [24].
1.4.6 Conformation-Dependent Cell Adhesion
As described in Section 1.4.5, fibronectin can exist in a variety of conformations,
and changes in conformation can result in altered cell adhesion characteristics.
In particular, changes to the arginine-glycine-aspartic acid (RGD) cell-binding
peptide loop on the III10 module of the fibronectin molecule have important
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implications for adhesion.
The RGD loop plays an important role in binding many cell-surface inte-
grins, including the α5β1 and αvβ3 integrins [15] (see Section 1.4.7 for details).
The III10 module containing the RGD loop is one of the least mechanically-stable
modules of fibronectin and is easily disrupted by strain. Even small strains (in-
sufficient to cause unfolding) can change the angle of the RGD loop enough, rel-
ative to the neighbouring synergy site on the III9 module, to inhibit α5β1 binding
in a conformation-dependent way [25].
1.4.7 Integrin Binding Model for Cell-Fn Adhesion
Cell-fibronectin adhesion in the work presented here is largely mediated by two
important cell-surface integrins (receptors), named the α5β1 and αvβ3 integrins.
The αvβ3 integrin (historically known as the vitronectin receptor [26]), binds to
the RGD loop found on the III10 module of fibronectin. Meanwhile, the α5β1 in-
tegrin simultaneously binds both the III10 RGD loop and the synergy site found
on the neighbouring III9 module, requiring both to be in close spatial proxim-
ity. Hence, α5β1 binds to fibronectin in a conformation-dependent manner, with
binding activity suppressed in extended and unfolded conformations where the
III9 and III10 modules are separated [27].
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1.4.8 Model Cell Lines Used for Cell Culture Studies
3T3-L1s as a Model for Fibroblasts/Stromal Cells
Fibroblasts are well-known for their role in producing and organizing the extra-
cellular matrix, both in healthy and diseased (cancerous) tissues [28, 29]. To this
end, a well-characterized murine preadipocyte cell line (3T3-L1) [30] was used
for the majority of studies, and was chosen as being representative of fibrob-
last/stromal cells. Choosing this cell line that is well-studied and widely-used
in the tissue engineering field enables the use of established protocols and com-
parisons to be made of observed cell behaviour with those in the literature.
MDA-MB231s as a Model for Tumour Cells
The MDA-MB231 cell line is a highly invasive metastatic breast cancer cell line,
and was chosen as a representative model for diseased (cancerous) tissues.
1.5 Optical Microscopy Characterization Methods
1.5.1 FRET-labelled Fibronectin to Assess Conformation
In order to study the conformation of proteins in our system, a technique is
clearly needed which is able to assess conformational changes. We utilized
an optical techinque – Fo¨rster Resonance Energy Transfer (FRET) – compatible
with cell culture, our polymer devices, and standard confocal light microscopy.
By labelling fibronectin molecules with chromophores that have appropriate
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emission-excitation spectral overlaps, the fibronectin molecules became opti-
cally active in a conformation-dependent manner, thus enabling us to directly
probe the conformation of adsorbed fibronectin in our system.
This section describes the FRET phenomenon, how it is employed with
chromophore-labelled fibronectin molecules, and how measurements are per-
formed to assess conformation.
1.5.2 Fo¨rster Resonance Energy Transfer (FRET)
Fo¨rster Resonance Energy Transfer (FRET) is a non-radiative transfer of en-
ergy from one or more “donor” chromophores to one or more “acceptor” chro-
mophores via a dipole-dipole coupling interaction. The process was first de-
scribed by Theodor Fo¨rster in 1948 [31]. Efficient energy transfer is dependent
on: 1) the spatial separation of the two chromophores; 2) the spectral overlap
of the donor emission spectrum with the acceptor absorption spectrum; and 3)
the relative orientation of the dipole moments of the donor and acceptor chro-
mophores.
The FRET efficiency E can be thought of as the quantum efficiency of the
energy transfer process; i.e., the number of transfer events that occur per donor





where r is the donor-to-acceptor separation distance, and R0 is the Fo¨rster radius
for a given donor-acceptor pair (i.e., the separation at which the energy transfer
efficiency in Eq. (1.1) is equal to 50%).
20
Of note is the very strong r−6 dependence, indicating that the energy transfer
exhibits a strong sensitivity to the spatial separation of the fluorophores. Given
that a typical value for R0 is roughly 10nm, the length-scale associated with
FRET makes it candidate as a “molecular ruler” type of tool, able to provide
information on distances at the molecular scale. For the particular FRET pair
used in this work (Alexa Fluor 488 donor and Alexa Fluor 546 acceptor), the
Fo¨rster radius is R0 = 6.4nm.
1.5.3 Fibronectin Labelling Scheme
A schematic of the Fibronectin labelling scheme is shown in Figure 1.9. The
scheme utilizes four acceptor fluorophores per Fn dimer (two per monomer)
attached to the cysteine residues of the III7 and III15 modules, and ten donor
fluorophores (five per monomer) randomly attached to lysine-containing mod-
ules. This scheme was optimized through prior work [19] to exhibit sensitivity
over a maximum range of fibronectin strain (in contrast to a 2-donor, 2-acceptor
scheme that is only sensitive to small strains). Depending on the molecular con-
formation of a labelled fibronectin molecule, the spatial overlap of the donor
and acceptor fluorophores will increase (compact conformation) or decrease
(extended to unfolded conformations). This can be assessed by measuring the
emission spectra of the donor and acceptor fluorophores simultaneously, and





where IAcc and IDon are the emission intensities of the Acceptor and Donor fluo-
rophores, respectively.
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Figure 1.9: (a) Fluorophore labelling scheme for FRET-labelled fibronectin
(Fn). A Fn dimer is shown with four acceptor fluorophores at-
tached at the III7 and III15 positions of each arm, and ten donor
fluorophores attached at random positions. The yellow circles
represent the Fo¨rster radii of the fluorophores (R0 = 6.4 nm,
omitted on donors for clarity). (b) Calibration curve of FRET
ratio (i.e., acceptor intensity/donor intensity) and correspond-
ing colour map as a function of chemical denaturant (guani-
dine hydrochloride) concentration. The schematics at left cor-
relate FRET ratio (and colour map) to protein conformations
obtained via circular dichroism measurements of free dilute
molecules in solution. Reproduced with permission from Wan
et al. (2012) [11].
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In a compact conformation, large spatial overlap of the fluorophores leads to
highly efficient energy transfer (Eq. (1.1)) from donor to acceptor. This results
in (relatively) low intensity emission from the donor (green), and high intensity
emission from the acceptor (red), resulting in a high FRET ratio.
Conversely, in a more extended conformation, decreasing spatial overlap
leads to less efficient energy transfer. This results in higher intensity emission
from the donor (green), and lower intensity emission from the acceptor (red),
resulting in a lower FRET ratio. High sensitivity is also achieved at extended
and unfolded conformations, because inter-monomer FRET is eliminated in ex-
tended conformations, followed by intra-monomer FRET being eliminated in
unfolded conformations due to increasing spatial separation of fluorophores.
Importantly, < 10% of the total fibronectin used in any experiment is FRET-
labelled (i.e., > 90% is unlabelled). This threshold was previously found to re-
strict FRET to intramolecular FRET, as opposed to intermolecular FRET due to
a high fluorophore concentration, which would artifically raise the measured
FRET value.
1.5.4 Confocal Microscope Measurements
FRET imaging can be performed on a (confocal) microscope with at least two
separate emission detectors, allowing simultaneous measurement of the donor
and acceptor emission spectra. Confocal microscopy enables imaging in a thin
plane of focus (achieved via “point”-illumination and reduction of defocused
light with a spatial pinhole) [32], allowing “z-stacks” of images to be acquired
through the height of a sample (i.e., imaging slices of a 10µm-thick layer of
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protein laid down by cells).
Measurements were performed on a Zeiss LSM 710 Laser Scanning confocal
microscope in the Cornell Life Sciences Core imaging facility. The microscope
features two photomultiplier tube detectors (PMTs) with tunable wavelength
detection ranges, allowing for simultaneous imaging of the donor and acceptor
fluorophores.
The detection ranges of interest were 514nm to 526nm for the donor and
566nm to 578nm for the acceptor, corresponding to the emission maxima of the
Alexa Fluor 488 and 546 fluorophores, respectively.
1.5.5 Spatial Resolution
Since imaging is performed with an optical microscope, the spatial resolution of
this technique is at best diffraction-limited [33]. In an optical microscope, light
of wavelength λ, travelling in a medium with refractive index n and converging
to a spot with angle θ, will focus to a spot of radius
d =
λ
2 (n sin θ)
(1.3)
also known as the Abbe diffraction limit [34]. The term (n sin θ) is the numerical
aperture (NA) of the optical system, which can reach about 1.4 with modern
optics. Thus, the Abbe limit is roughly d ≈ λ/2 to λ/3, limiting spatial resolution
to no better than ∼200nm.
This implies that the FRET-labelling strategy employed here cannot provide
information about the conformation of individual Fn molecules. Rather, the
ensemble average FRET ratio from many molecules in a small volume (or within
24
a fibronectin fiber) provides statistical information about the local conformation
of Fn molecules. This is not a problem for the task at hand, as we are interested
in average conformational changes over larger scales than individual molecules.
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CHAPTER 2
ELECTRICAL CONTROL OF CELL ADHESION ON CONDUCTING
POLYMER SURFACES
2.1 Contributors
This project was the initial collaboration between the former Malliaras group
and the Fischbach group. Daniel Brooks (former lab manager in the Fischbach
group) was instrumental in teaching and helping me with the cell-culture and
imaging techniques that were required for this work. Claudia Fischbach pro-
vided invaluable guidance from the biomedical perspective at this early stage in
the collaboration. George Malliaras proposed the initial project idea and helped
design the original device architecture, and contributed tremendously to the
rapid preparation of the manuscript – our total time of one month from start to
acceptance is surely some sort of record!
2.2 Abstract
We describe a conducting polymer device that can induce electrically-controlled
density gradients of normal and cancerous cell lines, and hence can be used as
a tool for the study of cell-cell interactions.




Gradients in cell density control the functions of normal and pathological tis-
sues by regulating the quality and quantity of cell-cell interactions. For example,
spatial variations in cell density lead to the generation of growth factor gradi-
ents, which, in turn, influence cell migration, proliferation, and differentiation
[36, 37]. Additionally, gradients in cell density can impact the number of phys-
ical connections a cell is able to form with neighbouring cells, which modulate
intracellular signalling pathways and affect cell behaviour [38]. Perturbation of
cell interactions in normal tissues (e.g., due to injury) typically triggers a cas-
cade of events that re-establishes tissue homeostasis. However, in pathological
tissues (e.g., tumours) these control mechanisms are dysfunctional and can lead
to impaired tissue functions and patient prognosis [39]. The ability to establish
controllable cell density gradients is critical to gaining a better understanding
of the underlying cellular and molecular mechanisms.
A variety of techniques can be used to generate spatially controlled varia-
tions in cell density. For example, artificial, growth factor-sequestering extra-
cellular matrices allow to probe the synergy between interstitial fluid flow and
growth factor signalling on the formation of endothelial cell gradients [40]. Ad-
ditionally, microfluidic devices capable of generating morphogen gradients pro-
vide useful tools to establish local variations in cell density as a result of directed
cell migration [41]. These systems permit to establish gradients in cell density
as a function of varying mechanical and chemical cues, but whether electrical
stimuli may be used in a similar manner has not been investigated.
In 1994, Wong, Langer and Ingber discovered that aortic endothelial cells
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grow differently on oxidized and on reduced polypyrrole films [42]. Since con-
ducting polymers such as polypyrrole can be reversibly switched between oxi-
dized and reduced states, these experiments pave the way for non-invasive con-
trol of cell growth. Subsequent work focused predominantly on neurons, where
the stimulation of neurite outgrowth is important for, among other things, re-
pair of spinal cord injury [43]. The topic of cell growth on conducting polymer
surfaces is currently receiving renewed attention due to the interest in organic
electronics [9]. A recent example is the work by the Berggren group demonstrat-
ing differences in neural cell adhesion on reduced and on oxidised conducting
polymer electrodes [44].
2.4 Results and Discussion
In this Communication we report a device in which an applied bias causes a re-
dox gradient in a conducting polymer film, which, in turn, leads to the creation
of density gradients in normal and cancerous cells. We chose two cell lines that
are representative models of normal and cancerous cells for this demonstration:
The 3T3-L1 (ATCC CL-173) cell line, which consists of mouse fibroblasts capable
of transforming into adipocytes and is representative of normal mesenchymal
cells, and the MDA-MB-231 (ATCC HTB-26) cell line, which is derived from hu-
man breast cancer and is representative of an aggressive and invasive form of
the disease.
Figure 2.1 shows the device that was used to create the redox gradients. A
3mm wide, 2.5 cm long indium tin oxide (ITO) stripe was deposited on a glass
substrate, onto which a PDMS reservoir that contained the cell growth medium
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Figure 2.1: Device schematic and chemical structure of PEDOT:TOS. The
inset shows a micrograph of MDA-MB-231 cells after perform-
ing a Live/Dead assay.
was attached. A ground electrode was immersed in the PDMS reservoir. A
bipolar power supply sourced −1.5V and +1.5V at opposite ends of the ITO
stripe (outside the PDMS reservoir), creating a linear potential gradient. A thin
film of the conducting polymer poly(3,4-ethylenedioxythiophene) doped with
p-toluenesulfonate (PEDOT:TOS) was deposited on top of the ITO stripe by
vapour phase polymerization [45]. Its conductance was about 100 times lower
than that of the underlying ITO stripe, and as a result it just replicated the local
surface potential of the ITO. The linearity of the gradient was confirmed by mea-
surements of surface potential, which was found to vary inside the PDMS reser-
voir between −1 and +1 V. Under this bias configuration, positive ions from the
growth medium enter the PEDOT:TOS film near the negatively-biased end. The
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local hole density decreases in order to maintain charge balance and the film is
reduced. In a similar fashion, oxidation takes place near the positively-biased
end, creating a redox gradient along the length of the PEDOT:TOS stripe. The
redox gradient is accompanied by a characteristic colour change across the film
[46]. It should be noted that without the underlying ITO stripe, the change of
conductivity associated with ion uptake in the PEDOT:TOS films would result
in highly non-linear potential gradients which might lead to ill-defined redox
gradients.
Cell growth medium was added to the PDMS reservoir and the devices were
biased for 1hour to establish the redox gradient on the PEDOT:TOS. The bias
was then removed and the cells were seeded. Hence, cell growth took place in
the absence of applied bias. The colour change that accompanied the establish-
ment of the redox gradient was immediately visible following the application
of the bias and remained stable for the duration of the experiment, without no-
ticeable change when the bias was removed. Cells were seeded on the device
and allowed to grow for 24hours before their viability was quantified with a
Live/Dead assay, using Calcein AM (green, calcein acetoxymethyl ester; Invit-
rogen C1430) for live cells, and Propidium Iodide (red, Sigma-Aldrich P4170)
for dead cells. Seeding densities were ∼15 000 cells/cm2 for the 3T3-L1 cells and
∼30 000 cells/cm2 for the MDA-MB-231 cells.
Figure 2.2 shows composite images mapping 3T3-L1 cell distributions along
the PEDOT:TOS stripe in two devices that were biased in opposite directions
from each other. Each composite consists of 6 individual fluorescence micro-
graphs, obained through a 2.5× objective with a Zeiss Axio Observer.Z1 micro-
scope. The images reveal regions of low cell density, where individual cells are
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Figure 2.2: Fluorescence micrographs of calcein-green stained 3T3-L1 cells
for two devices biased in opposite directions.
well separated from each other, as well as regions where the cells are begin-
ning to form a confluent monolayer. From these plots it can be seen that large
density gradients can indeed be established on the PEDOT:TOS surface. More-
over, in both plots, the regions of low density are close to the negatively-biased
side of the PEDOT:TOS. Therefore, the direction of the cell density gradient is
controlled by the direction of the applied bias.
Figure 2.3 shows population densities obtained from analysis of fluorescence
images from both 3T3-L1 and MDA-MB-231 cells. The images were parsed in 20
segments along the length of the PEDOT:TOS stripe and the number of individ-
ual cells was counted using ImageJ (National Institutes of Health). The average
cell density, obtained from analysis of data from two devices was then plotted
as a function of the average local potential that was applied on each segment be-
fore seeding the cells. The experiment was repeated several times to ensure the
reproducibility of these observations. The data shows that both types of cells
prefer the oxidized side of the PEDOT:TOS film, and the cell density decreases
gradually towards the reduced side of the film. It should be noted that quantifi-
31
Figure 2.3: Population densities for 3T3-L1 cells (a) and MDA-MB-231
cells (b) across the PEDOT:TOS film.
cation of the total cell surface area at different locations of the established cell
density gradient yielded similar results.
The observed density gradients are not caused by a change in the viability of
the cells along the PEDOT:TOS film. The inset of Figure 2.1 shows a typical mi-
crograph (phase-contrast, green and red fluorescence at 10×) of the MDA-MB-
231 cells from a reduced region of PEDOT:TOS after performing the Live/Dead
assay. In this image green fluorescence corresponds to live and the red to dead
cells, indicating that the majority of the cells are alive. Cell viability was found
to exceed 98±1% regardless of the redox state of the PEDOT:TOS film. The 3T3-
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L1 cells also showed similarly high viability on all regions of the PEDOT:TOS
film. Cells grown on a control device that was never biased also showed the
same viability. It should be noted though that if the applied bias is not removed
prior to seeding the cells, their viability and morphology are quickly and ad-
versely affected. In an experiment where the bias was maintained during cell
culture, changes in cell morphology were detectable less than 30 minutes after
seeding. After less than 2.5hours of culture, nearly all adhered cells on the de-
vice had lost viability, as confirmed with a Live/Dead assay. It is likely that the
observed cell density gradients arise due to differences in cell adhesion. The lat-
ter is mediated in part by the adsorption of adhesion proteins (e.g. fibronectin)
that are contained in the serum of the growth medium. An immunostaining
assay was performed to quantify fibronectin (FN) adsorption on different lo-
cations of the device. Devices were incubated under bias for 1 hour in a FN
solution diluted in DI water. The concentration of FN corresponded to an area
density of 15micro g/cm2 for each device.
The FN was fixed with neutral-buffered formalin for 30 minutes and the de-
vices were washed twice in phosphate buffered saline (PBS) with 0.5% bovine
serum albumin (BSA) to prevent non-specific binding of the primary antibody.
The devices were then incubated for 1 hour in a 1:400 dilution of the anti-
fibronectin primary antibody in PBS/BSA. The devices were washed twice with
PBS/BSA and incubated for 1 hour in the dark in a 1:100 dilution of a fluores-
cent goat anti-rabbit secondary antibody in PBS/BSA. Subsequent washing and
imaging of the fluorescence from the secondary antibody revealed the relative
concentration of adsorbed fibronectin. The data were corrected for the depen-
dence of the optical density of PEDOT:TOS on its redox state and are shown
in Figure 2.4. The control corresponds to a device that was never biased. The
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Figure 2.4: Quantification of adsorbed fibronectin as a function of the re-
dox state of PEDOT:TOS.
data show that a redox gradient across a PEDOT:TOS film causes a gradient
in adsorbed fibronectin concentration, with concentration decreasing from the
reduced towards the oxidized side.
The higher concentration of adsorbed fibronectin on the reduced side of the
device would imply better cell adhesion, leading to a higher cell density [47],
which is the opposite of what we find here. The reason for the higher cell den-
sity on the oxidized side of PEDOT:TOS is currently not understood. A similar
finding was recently reported by the Berggren group [44]. In a study of adhe-
sion of c17.2 neural stem cells on reduced and oxidized conducting polymer
electrodes, they showed a higher density of attached cells on the oxidized elec-
trode. Moreover, they also showed that human serum albumin adsorbs pref-
erentially to the reduced electrode. It was hypothesized that the orientation of
adsorbed protein at the two electrodes might be different, or that the higher
protein concentration on the reduced electrode might have a blocking effect on
extracellular matrix proteins and hinder cell adhesion [44]. Understanding the
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physics of protein adsorption on conducting polymer surfaces will be a major
step towards uncovering the pathways leading to non-invasive, electrical con-
trol of cell adhesion. The device described here can create cell density gradients
that range from isolated, well-spaced cells to confluent monolayers, and these
are suitable for the study of cell-cell interactions. Compared to other techniques
that can yield similar cell density gradients, it offers the advantages of simplicity
and electrical control: There is no need for precise patterning of chemical cues
on a surface the redox gradient is established automatically and its direction
can be controlled by the applied bias. The spatial extent of the gradient (here,
∼1 cm long) can be controlled by the dimensions of the conducting polymer film,
or the applied bias. Moreover, the device described here offers open access to
the cells an advantage over microfluidic techniques. Yet, conducting polymer
devices similar to the one reported here have been integrated with microfluidic
channels [48]. Therefore, electrical control of cell density gradients can also be
obtained in a microfluidic format for systems-on-a-chip applications.
2.5 Conclusions and Perspectives
We described a simple device that can be used to establish redox gradients on a
conducting polymer film. When cells are cultured on this film, density gradients
are established. This was demonstrated for both normal and cancerous cells. A
variation in the density of adsorbed fibronectin implies that the device works
by controlling cell adhesion.
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CHAPTER 3
ELECTRICAL CONTROL OF CELL MOTILITY USING A CONDUCTING
POLYMER DEVICE
3.1 Contributors
This project was a collaboration between the former Malliaras group and the
Reinhart-King group in Biomedical Engineering. The work was completed in
parallel with the Cell Adhesion project described in Chapter 2, utilizing the
same device architecture. The majority of the experimental work was car-
ried out by Abdurrahman Gumus (a former graduate student in the Malliaras
group), and Joseph Califano (a former graduate student in the Reinhart-King
group).
3.2 Abstract
Control of cell migration is receiving a great deal of attention due to its rele-
vance to the engineering of tissues. Here we report a device that consists of a
conducting polymer stripe and achieves a continuum of microenvironments for
cell growth under the influence of an applied bias. Marked differences are ob-
served in the migration behaviour of bovine aortic endothelial cells (ECs) as a
function of location along the polymer stripe, and a 3-fold variation is achieved
in EC migration speed and directional persistence time. Moreover, the device
induces directional cell migration along the conducting polymer stripe. A gra-
dient in adsorbed fibronectin indicates that a spatial variation in cell adhesion
This work was published in Soft Matter in 2010 [49]. All figures reproduced with permission.
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is at play. The ability to control cell migration behaviour using external elec-
trical stimuli highlights the potential of using conducting polymers as “active”
substrates for the non-invasive control of cell behaviour.
3.3 Introduction
Cell motility (movement) is not surprisingly related to adhesion characteris-
tics. In particular, the speed of migration is dependent on adhesion strength.
DiMilla and coworkers showed that cell speed exhibits a maximum at a certain
level of cell-substratum adhesiveness [50]. This maximum occurs between the
two extremes of excessively low adhesiveness that prevents cells from exert-
ing adequate contractile forces to move, and excessively high adhesiveness that
prevents cells from releasing their trailing edges during migration (Figure 3.1).
The directed assembly of cells into tissues is critical to embryonic develop-
ment, wound healing and the engineering of tissues for organ regeneration and
replacement [51]. Cell migration, which facilitates proper spatial localization
during tissue formation, is largely controlled by the chemical and structural
cues in the microenvironment that are integrated by the molecular machinery
of cells. As a result, the engineering of well-defined extracellular matrix en-
vironments that control cell migration by altering the chemical, mechanical or
structural properties of the extracellular scaffold [52] is receiving a great deal of
attention.
Tissue engineering largely focuses on developing materials that induce
physiological cell migration and tissue assembly by incorporating the extracel-
lular cues found in vivo. It is well-established that soluble and insoluble chem-
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Figure 3.1: A biphasic relationship between dimensionless cell-
substratum adhesiveness κ and dimensionless cell speed
ν can arise when bond distribution asymmetry results from a
spatial variation in strength of adhesion-receptor ligand bind-
ing. Ψ is the ratio of uropodal to lamellipodal adhesiveness.
Values of Ψ near unity correspond to small differences in bond
affinity between front and rear of the cell, and the cell moves
at nontrivial speeds over a restricted range of adhesiveness.
Decreasing Ψ leads to the generation of greater adhesion-bond
asymmetry, and cell movement can occur over a larger range
of adhesiveness. Reproduced with permission from DiMilla et
al. [50].
ical gradients [53, 54], gradients in mechanical stiffness [55, 56] and micro- and
nano-topographical features [57] can be exploited to direct and/or enhance cell
migration. It is known that cells can respond to chemical gradients of growth
factors through chemotaxis and haptotaxis, and gradients in mechanical stiff-
ness through durotaxis. As such, many biomaterials and devices have been
engineered by using novel polymers, chemical conjugation techniques or mi-
crofluidics to present well-defined chemical or mechanical gradients to cells
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The goal of these platforms has been to induce cell migration as a critical
step in forming replacement tissues. Many of the current strategies have lim-
itations. In the case of chemotaxis-based approaches, it has been difficult to
achieve long-term, stable gradients to induce cell migration on an implantable
device. In durotaxis, most materials that have been developed to incorporate
tunable, well-defined mechanical gradients are not biocompatible and would
not be suitable for implantation. Therefore, there is a clear need to develop
better strategies to reliably and easily control cell migration using a method
amenable to implantation.
The emergence of organic electronics – a technology that relies on carbon-
based semiconductors to deliver devices with unique properties [9] – creates
tremendous opportunities at the interface between electronic materials and liv-
ing cells [58]: The soft nature of organics offers better mechanical compatibility
with tissue than traditional electronic materials, while their natural compati-
bility with mechanically flexible substrates suits the non-planar forms often re-
quired for biomedical implants [59]. Their ability to conduct both ionic and
electronic charges opens up a new communication channel with electrically ac-
tive cells [60, 61]. Finally, the fact that the electronic properties of organics can
be switched on or off in response to electrical stimuli [62] creates opportunities
to use these materials as active substrates for cell growth.
In 1994, Wong et al. discovered that ECs grow differently on oxidized versus
reduced polypyrrole films [42]. Since conducting polymers such as polypyrrole
can be reversibly switched between oxidized and reduced states, these exper-
iments paved the way for non-invasive control of cell behaviour by electrical
means. More recently, devices based on a conducting polythiophene have been
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used to demonstrate electrical control of cell adhesion [44], and the creation of
density gradients in normal and cancerous cell lines [35].
3.4 Results and Discussion
In this chapter we demonstrate that organic electronic devices enable the electri-
cal control of cell migration, hence they can serve as vehicles to help understand
and engineer tissue formation. A device that allows one to create a continuum of
microenvironments for cell growth is shown in Figure 3.2. An indium tin oxide
(ITO) stripe was deposited on a glass substrate, onto which a polydimethylsilox-
ane (PDMS) reservoir containing cell growth medium was attached. A ground
electrode was immersed in the PDMS reservoir.
A bipolar power supply sourced −1.5V and +1.5V at opposite ends of the
ITO stripe (outside the PDMS reservoir), creating a linear potential gradient. A
thin film PEDOT:TOS was deposited on top of the ITO stripe by vapor phase
polymerization. Its conductance was about 100 times lower than that of the un-
derlying ITO stripe, and as a result it replicated the local surface potential of
the ITO. The linearity of the gradient was confirmed by measurements of sur-
face potential, which was found to vary between −1 and +1V inside the PDMS
reservoir.
Under this bias configuration, positive ions from the growth medium enter
the PEDOT:TOS film near the negatively-biased end. The local hole density
decreases in order to maintain charge balance and the film is reduced. In a
similar fashion, oxidation takes place near the positively-biased end, creating a
redox gradient along the length of the PEDOT:TOS stripe. The redox gradient
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Figure 3.2: Device schematic and chemical structure of PEDOT:TOS. The
inset shows a micrograph of endothelial cells adhered to the
PEDOT:TOS surface.
is accompanied by a characteristic colour change across the film [46]. It should
be noted that without the underlying ITO stripe, the change of conductivity
associated with ion uptake in the PEDOT:TOS films would result in highly non-
linear potential gradients which will fail to cause a well-defined continuum of
microenvironments for cell growth.
Cell growth medium was added to the PDMS reservoir and the devices were
biased for 1hour to establish the redox gradient on the PEDOT:TOS. The bias
was then removed and the cells were seeded. Hence, cell migration was observed
in the absence of applied bias. The colour change that accompanied the establish-
ment of the redox gradient was immediately visible following the application of
the bias and remained stable for the duration of the experiment, without notice-
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Figure 3.3: Trajectories of 6 ECs at a mildly reduced (a, V = −0.5V) and
at an oxidized (b, V = +0.9V) location of the PEDOT:TOS
stripe. The potential refers to the average local potential at a
PEDOT:TOS pixel, as it was applied before seeding the cells.
able change when the bias was removed. The devices were placed on a Zeiss
Axio Observer.Z1m inverted phase contrast microscope stage equipped with
a chamber maintained at 37degrees, 5% CO2, and 40% humidity. Cells were
plated at a density of 1500 cells/mL to minimize cell-cell collisions during mi-
gration and were allowed to adhere and spread for 6hours prior to observation.
Cell migration was measured using time lapse microscopy through a 10× lens,
with images taken every 10min for 6hours. One such image is shown in the
inset of Figure 3.2.
Images were acquired in five locations (pixels) across the PEDOT:TOS stripe
that corresponded to an average local potential, as it was applied before seed-
ing the cells, of −0.9V (reduced), −0.5V (mildly reduced), 0V (reference PE-
DOT:TOS), 0.5V (mildly oxidized), and 0.9V (oxidized). Figure 3.3 shows the
trajectories of six cells on the mildly reduced and oxidized pixels. Marked dif-
ferences in the observed trajectories indicate that the redox state of the polymer
significantly affects cell migration. Cells on the mildly reduced pixel seem to
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only explore their immediate neighbourhood, as most of them remain within
100µm from their origin during the 6 hour measurement period. On the other
hand, cells on the oxidized pixel follow more open trajectories, moving as far as
400µm away from their origin. It should be mentioned that in a control experi-
ment, no spatial differences were observed on EC migration along a device that
was not biased.
















yielded the speed S , and the directional persistence time P of cells located in
each pixel. Figure 3.4 shows the variation of S and P at the five pixels across
the PEDOT:TOS. The speed for ECs on the reference pixel is 10.8 ± 1.7µm/h,
consistent with values measured for ECs on glass [37, 64]. While reduction of
PEDOT:TOS does not have a significant effect on speed or persistence, oxida-
tion does: The speed on the oxidized pixel increases to 32.53.8µm/h, and a
similar 3-fold increase is observed in the persistence. These results show that
PEDOT:TOS can be used to electrically control cell migration behaviour. The
3-fold increase in speed achieved by oxidizing the PEDOT:TOS film compares
well to improvements measured using fluid shear stress [64, 65] and chemical
gradients [37] to induce migration. A larger change might be achievable using
a higher applied bias, but electrolysis in the cell medium becomes an issue.
Cell migration involves the formation of new attachments at the front of
the cell and the breaking of existing attachments at the rear. As a result, the
maximum migration speed is predicted to occur at an intermediate value of
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Figure 3.4: Migration speed and direction persistence time at various lo-
cations across the PEDOT:TOS stripe which are marked by the
average local potential, as it was applied before seeding the
ECs. * indicates p < 0.0001 compared to all other groups. Dash
indicates statistically similar groups.
cell-substrate adhesiveness [50]. Increasing or decreasing adhesion beyond this
optimum is therefore predicted to decrease cell migration speed. Cell adhesion
is mediated in part by the adsorption of adhesion proteins (e.g. fibronectin)
that are contained in the serum of the growth medium. We therefore conducted
an immunostaining assay to quantify the density of adsorbed fibronectin (Fn)
at different locations along the PEDOT:TOS stripe. The results, shown in Fig-
ure 3.5, reveal that the density of adsorbed Fn increases along the PEDOT:TOS
stripe from the oxidized to the reduced end. The observed changes in cell speed
along the PEDOT:TOS stripe can be understood by assuming strong EC adhe-
sion on the reduced parts of the PEDOT:TOS stripe. In this limit, cells find it
difficult to break existing attachments and their speed is low. The lower den-
sity of adsorbed Fn on the oxidized pixels would then decrease cell adhesion,
thereby increasing cell speed. This interpretation is consistent with the observa-
tion of Palecek et al., who have shown that increasing the density of adsorbed
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Figure 3.5: Fluorescence micrograph showing immunostained adsorbed
fibronectin (green) along the PEDOT:TOS stripe. The direction
of applied bias is indicated.
Fn above a certain value decreases cell speed [66].
An alternative interpretation is suggested by two recent studies of cell
growth on conducting polymer surfaces [35, 44]. Both studies showed a higher
density of attached cells on oxidized than on reduced PEDOT:TOS, suggesting
stronger cell adhesion on the oxidized part of the film. However, human serum
albumin and Fn were found to adsorb preferentially on reduced PEDOT:TOS.
This was reconciled by hypothesizing that the orientation and conformation of
the adsorbed protein at the two electrodes is different. According to these re-
ports, the observed changes in speed along the PEDOT:TOS stripe can be un-
derstood by assuming that EC adhesion on the reduced parts of PEDOT:TOS
stripe is below the optimum. In this limit, cells find it difficult to form new
attachments and their speed is low. Stronger cell adhesion on the oxidized PE-
DOT:TOS pixels increases cell speed. At this point it is not possible to distin-
guish between these two interpretations and the only conclusion that can be
drawn is that the redox gradient on the PEDOT:TOS establishes different mi-
croenvironments for cell growth. Understanding the physics of protein adsorp-
tion on conducting polymer surfaces will be a major step towards understand-
ing the changes in migration behaviour observed here.
Adsorbed Fn density gradients, prepared using counter-propagating self-
assembled monolayer techniques, are known to direct cell migration through
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haptotaxis [37, 67]. Not surprisingly, directional cell migration was found to
occur along the PEDOT:TOS stripe. Analysis of all cells trajectories on the ref-
erence pixel (which is located at the centre of the gradient) shows that there
is net 7.7µm migration (in 6hours) from the reduced to the oxidized part of
the PEDOT:TOS stripe. This displacement is similar in magnitude with values
measured on static Fn gradients [37, 67]. However, the direction of cell mi-
gration in static gradients is from low to high Fn densities, opposite to what is
observed here. This lends support to the hypothesis of stronger cell adhesion on
the oxidized part of the film, as haptotaxis leads cells toward regions of higher
adhesion [68].
3.5 Conclusions and Perspectives
Compared to other techniques that are used to control cell migration, the de-
vice discussed here offers the advantages of simplicity and electrical control,
and might yield a useful tool for cell biology. Migration can be slowed down
or accelerated, enabling the study of the signal transduction mechanisms gov-
erning cell speed, extension, sensing and directionality. Because these are the
same cell behaviours critical to multiple biological processes, including cancer
cell metastasis, inflammatory response, wound healing and embryonic devel-
opment, implementing such a device could lead to the identification and study
of molecular targets mediating these processes.
Multiple experiments could easily be assembled into one culture dish, en-
abling the study of multiple treatments and conditions simultaneously. More-
over, the device offers open access to the cells, an advantage over microfluidic
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techniques. Yet, conducting polymer devices similar to the one reported here
have been integrated with both traditional [3] and surface-directed [48] mi-
crofluidic channels. Therefore, electrical control of cell migration can also be
obtained in a microfluidic format for systems-on-a-chip applications.
Directed migration can be induced without the need for precise patterning
of chemical or mechanical cues on a surface – the redox gradient is established
automatically and its magnitude, direction, and offset can be controlled by the
applied bias. A smaller device, easily achievable with microfabrication, can sup-
port a steeper electrical gradient, creating an opportunity to control directional
cell migration. PEDOT:TOS is biocompatible [58], and therefore can be incor-
porated into current biomaterial designs to enhance cell infiltration into tissue
engineered constructs. As a wound healing dressing, for example, the use of
PEDOT:TOS may decrease healing time by increasing directional cell migration
into the wound. PEDOT:TOS redox gradients offer an easy-to-use, tunable plat-
form which could be easily integrated into biomedical devices.
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CHAPTER 4
ELECTRICAL CONTROL OF PROTEIN CONFORMATION
4.1 Contributors
This project was an extended collaborative effort between the (former)
Malliaras, Ober, Fischbach, and Gourdon groups. Delphine Gourdon in par-
ticular provided tremendous (and timely) expertise regarding the terribly com-
plicated realm of FRET measurements. Several times, her ability to see things in
raw data that I had missed was critical in moving the project foward to (even-
tual) successful completion. Becky Schur (a former M.S. student in the Gourdon
group) performed timely, reliable AFM measurements that made my life much
easier. George Malliaras and Delphine Gourdon contributed tremendously to
the preparation of the manuscript.
4.2 Abstract
We report conducting polymer devices that enable precise control of fibronectin
conformation over macroscopic areas. Single conformations as well as confor-
mation gradients are achieved by applying an appropriate potential. These sur-
faces remain biologically relevant and support cell culture; hence, they may
serve as a model to understand and control cell-surface interactions, with ap-
plications in basic research, medical diagnostics, and tissue engineering.




Fibronectin (Fn) is a prominent extracellular matrix (ECM) glycoprotein that
regulates cell adhesion [15], migration [16], differentiation [17], and growth [18],
during processes such as embryonic development and tissue remodeling. Con-
formational changes of Fn are critically important in guiding these cell functions
and have, for example, been linked to pathologies ranging from fibrosis to can-
cer [15, 69].
Here we report conducting polymer devices that enable precise control of
protein conformation over macroscopic areas. Surfaces with single Fn confor-
mations, as well as conformation gradients ranging from compact to unfolded,
are achieved by applying the appropriate potential across the device. Impor-
tantly, the stiffness and topography of these surfaces remains unchanged, of-
fering the potential to study protein conformation in isolation. These surfaces
remain biologically relevant and support cell culture, therefore, they can enable
a better understanding of the critical link between protein structure and func-
tion, with the ultimate goal of controlling cell-surface interactions. As such, they
represent a new tool for biological research with many potential applications in
basic research, medical diagnostics, and tissue engineering.
Proteins play a prominent role in guiding biological signaling and function,
and it is their (often variable) conformation that governs their multiple bio-
logical functions. Previously, conformational changes in single molecules and
macromolecular assemblies of proteins (including Fn) have been controlled and
studied with techniques such as AFM [70, 71], MEMS actuators [22] and opti-
cal/magnetic tweezers [72, 73]. While these studies provide crucial insights into
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protein structure and associated function, they are limited to controlling pro-
tein conformation over nanoscopic to microscopic areas, and mostly under non-
physiological conditions, preventing their application in the presence of cells.
Moreover, the microscopic and sophisticated nature of these experiments makes
it very challenging to integrate them with common cell culture and biochemical
analysis techniques that typically require the use of large populations of cells,
and to readily apply them in conventional biological labs. Macroscopic surfaces
with a precisely controlled protein conformation may be able to overcome these
shortcomings and provide innovative tools for a broad range of physical and
biological experiments.
Conducting polymers are known to be “smart materials” whose properties
change upon oxidation/reduction, and this has spurred interest in their applica-
tion at the interface with life sciences [58, 74]. In addition to having switchable
properties, conducting polymer films are optically transparent, cytocompatible,
and can be processed over large areas using low-cost fabrication techniques,
rendering their integration with cell cultures facile. In one experiment, the re-
dox state of polypyrrole was shown to affect cell adhesion [42], paving the way
for smart Petri dishes that enable control of cell density on their surface. A re-
cent study of cell viability and adhesion of epithelial cells on a conducting poly-
thiophene suggested that changes in protein conformation underlie this effect
[75], but no direct measurement of protein conformation was performed.
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4.4 Results and Discussion
In this work we use Fo¨rster Resonance Energy Transfer (FRET) imaging [19] to
directly assess Fn conformation on the surface of the cytocompatible conducting
polymer [76] poly(3,4-ethylenedioxythiophene) doped with p-toluenesulfonate
(PEDOT:TOS). We demonstrate two device configurations that achieve precise
electrical control of protein conformation: One that establishes smooth gradi-
ents in Fn conformation, and another that establishes uniform Fn conformations
over single, large area pixels. We used Fn molecules that were labeled for FRET
and carried out a calibration measurement according to the scheme shown in
Figure 1.9. We first measured FRET in solution as a function of increasing chem-
ical denaturant concentration (guanidine hydrochloride, GdnHCl). The mea-
surements were performed on a confocal microscope by simultaneously imag-
ing both FRET fluorophores in separate channels, and calculating the FRET ra-
tio as the acceptor fluorophore intensity (IA) divided by the donor fluorophore
intensity (ID). We subsequently measured Fn conformation as a function of
GdnHCl concentration via circular dichroism [19], and thus deduced a calibra-
tion curve of FRET ratio as a function of Fn conformation.
The device used to create gradients in Fn concentration consisted of a 2 cm-
long, 0.7 cm-wide PEDOT:TOS film on top of an indium tin oxide (ITO) film of
similar dimensions (Figure 4.1). A gradient in surface potential was established
by applying ±1.0V across this stripe while it was incubated for one hour in cell
culture medium containing Fn. The underlying ITO film was used to ensure the
linearity of the potential gradient, as conducting polymers are known to change
their conductivity upon oxidation/reduction. This device configuration led to
the establishment of a redox gradient along the PEDOT:TOS stripe, with the
51
most oxidized part close to the positive side of the device and the most reduced
part close to the negative side. The incubation medium contained 30µg/mL of
Fn purified from human plasma, with less than 10% of the Fn labeled for FRET.
This allowed us to assess protein conformation via analysis of intra- rather than
intermolecular FRET [76]. We found that the applied bias established a mono-
tonic gradient in FRET ratio, indicating a gradient in Fn conformations that var-
ied smoothly from compact conformation at the oxidized end of the polymer
stripe, to unfolded conformation at the reduced end of the polymer stripe (Fig-
ure 4.1a).
A second device configuration, consisting of two 1×0.7 cm2 PEDOT:TOS pix-
els held at different potentials, was used to establish uniform Fn conformations.
As in the previous device configuration, underlying ITO films were used to keep
the potential of the pixels well-defined. In the example shown in Figure 4.1b,
one of the pixels was brought to the most oxidized (+1V) state, and the other
to the most reduced (−1V) state, while incubating in Fn-containing cell culture
medium as before. Subsequent FRET imaging of the two pixels showed a uni-
form high FRET ratio (compact conformation) on the oxidized pixel and low
FRET ratio (unfolded conformation) on the reduced pixel, respectively.
In order to assess the biological activity of the prepared Fn surfaces, we
cultured mouse fibroblasts (3T3-L1) on both the oxidized and reduced pixels.
Specifically, we seeded the cells on the different surfaces, and then quantified
differences in cell adhesion by counting the number of adhered cells and as-
sessing cell morphology 3 hours later. While overall morphology (spreading
area, cytoskeletal arrangement) was not significantly different, the number of
adhered cells was different on the two pixels, with 60% more cells adhering to
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Figure 4.1: FRET ratios on the gradient (a) and pixel (b) devices as a func-
tion of applied bias and position. Images were taken at the
locations indicated by open black squares, and the surface was
interpolated. Colour of the surface indicates local Fn conforma-
tion as described in Figure 1.9b, and corresponding schematics
of conformation are shown above the surface. The inset shows
the device configuration.
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the oxidized than to the reduced one. We hypothesized that the difference in
cell adhesion was mediated by α5β1 integrins – one of the major membrane re-
ceptors responsible for cell adhesion to Fn [77] – and that the ability of these
integrins to bind to the oxidized vs. reduced pixels was altered due to confor-
mational changes of adsorbed Fn. α5β1 recognizes the synergy and arginine-
glycine-aspartic acid (RGD) sites in the III9−10 modules of Fn [78, 79], and its
binding affinity to Fn could be altered by Fn unfolding as this would change
the spatial separation of the RGD and synergy sites. We tested this hypothe-
sis by introducing a β1 function-blocking antibody to inhibit α5β1 binding, and
observed that the differences in number of cells adhering to the oxidized and
reduced pixels vanished (Figure 4.2). This response additionally indicated that
the adsorbed Fn retained its biological activity and one of its primary functions;
i.e., to support α5β1 integrin binding.
Changes in Fn conformation, as well as changes in the redox state of a con-
ducting polymer, may both be associated with modified mechanical [22] and/or
topographical properties. Therefore, we used AFM to assess the elasticity (un-
der compression) and surface roughness of the Fn-coated polymer pixels under
different redox states. AFM measurements on the oxidized and reduced pix-
els (with adsorbed Fn), in buffer, yielded identical average Youngs modulus
(90kPa) and root-mean-square roughness (7nm) for both.
We observed that the pH of the αMEM solutions (initially at physiological
pH 7.4) attained pH values of 7.1 and 7.7 above the oxidized and reduced pix-
els, respectively. The observed changes of protein conformation may be related
to local changes in pH near the surface of the conducting polymer. Changes in
pH are known to affect protein conformation; in particular, Fn achieves more
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Figure 4.2: Relative number of adhered 3T3-L1 mouse fibroblasts on fully
oxidized (+1 V) and reduced (−1 V) pixels, for varying doses of
a β1 function-blocking antibody. Cell numbers were recorded
after 3 hours of incubation and are normalized to the values on
the reduced pixels. (∗P < 0.01, unpaired t-test).
extended or unfolded conformations at higher pH levels [80]. This is in agree-
ment with our findings that a lower pH over the oxidized pixel corresponds to
a compact conformation of Fn, and a higher pH over the reduced pixel corre-
sponds to an unfolded conformation of Fn. It should be noted that a lowering
of pH over the oxidized pixel is consistent with expulsion of protons from the
PEDOT:TOS film into the electrolyte, which is more negative. Similarly, protons
in the neighbourhood of the reduced pixel will be driven into the PEDOT:TOS
film, decreasing proton density in the electrolyte over the pixel and increasing
the local pH.
Our experiments show that the conformation of adsorbed Fn can be varied
continuously from compact, to extended, to unfolded by means of applying a
linear potential gradient to a conducting polymer stripe. The FRET gradient
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shown in Figure 4.1a provides, in essence, a calibration curve that maps the
various conformations to a corresponding potential applied to the conducting
polymer. Accordingly, one can select a desired protein conformation, and uni-
formly establish that conformation across a macroscopic surface by applying
the corresponding potential on a conducting polymer pixel. In the particular
setup described above, the size of the conducting polymer pixels was much
larger than the size of individual cells and is therefore suitable for experiments
with cell cultures. Pixels can, however, be made with dimensions on a cellu-
lar, or even on a sub-cellular level, providing a vehicle to study the influence
of protein conformation on cell behaviour and signalling across multiple scales.
Additionally, both stiffness and topography remain unaltered upon voltage ap-
plication, showing that our technique allows control over protein conformation
in isolation, and, therefore, enables studies of cell behaviour exclusively as a
function of this variable.
The difference in cell adhesion between the compact and unfolded Fn pix-
els is consistent with a well-established integrin binding model. In particular,
cell adhesion to Fn is largely mediated by α5β1 integrins, which bind simultane-
ously the arginine-glycine-aspartic acid (RGD) sequence and synergy site of Fn,
located on the neighbouring III10 and III9 domains of Fn, respectively [78, 79].
These two peptide sequences must be in close proximity to enable α5β1 binding,
which only occurs when Fn is in a compact conformation [25, 81, 82]. In the
extended to unfolded conformations, increasing spatial separation of the RGD
and synergy sites would progressively inhibit α5β1 binding, and thus weaken
adhesion. Introducing the β1 function-blocking antibody served to inhibit this
conformation-dependent adhesion mechanism, resulting in similar numbers of
cells adhering to both pixels.
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4.5 Conclusions and Perspectives
In conclusion, we have demonstrated electrical control of protein conforma-
tion over macroscopic areas. Gradients as well as uniform conformations of
adsorbed Fn can be established and are compatible with cell culture experi-
ments. Moreover, conformation is controlled independently of other relevant
parameters such as stiffness and surface roughness, which remain constant. As
such, these surfaces constitute a model to understand and control cell-surface
interactions. They will allow, for example, to study the effects of Fn conforma-
tional changes on cell function (i.e., adhesion, proliferation), and to tune the
latter by dialling in a specific conformation. Moreover, as conducting poly-
mers can be processed into many forms, including 3D architectures (e.g. hy-
drogels [83], electrospun networks [84], etc.), this method may pave the way to-
ward physiologically-relevant 3D platforms with precise control over adsorbed
protein conformation, with applications in tissue engineering and regenerative
medicine.
4.6 Supporting Information
FRET Measurements: Lambda scans (495nm to 580nm) were performed under
excitation from a 488nm laser on devices in the gradient configuration, both
with and without FRET-labelled Fn. The devices without Fn served as controls
to measure background autofluorescence from the underlying PEDOT:TOS and
ITO layers. A typical resulting lambda scan is shown in Figure 4.3a, and the
resulting FRET ratios are shown in Figure 4.3b. FRET ratios are calculated from
the lambda scan spectra by integrating the emission over the regions of interest
57
Figure 4.3: (a) Lambda scan of fluorophores emission intensity (after back-
ground subtraction) recorded as a function of potential on a
gradient device, with adsorbed FRET-labelled Fn. The verti-
cal dashed lines indicate the regions of interest for the donor
(514 − 526 nm) and acceptor (566 − 578 nm) fluorophores, re-
spectively. (b) FRET ratio (IAcceptor/IDonor) calculated from the
integrated emission of the lambda scan, in the appropriate re-
gions of interest.




CONDUCTING POLYMER SURFACES ALTER PROGENITOR CELL
ADHESION AND SECRETION
5.1 Contributors
This project was a strong collaborative effort with Emily Brooks in the Fischbach
group. Emily and I contributed roughly equally to the experimental work, an
are co-first-authors on the manuscript. I fabricated all of the PEDOT:PSS de-
vices, and performed all of the seeding experiments with Emily. Emily (along
with Maya Madhavan, an undergraduate in the Fischbach group) performed
all of the ELISA assays. Maya was instrumental in helping me finish the project
after Emily’s graduation and departure in July 2012. Maya continued to run
ELISAs and also collected the data and images for the cell-derived matrices and
the HUVEC migration assays.
Claudia Fischbach provided invaluable guidance throughout this project,
helping to guide the experimental designs and develop/prepare the
manuscript. The device architecture used in this work was a modification I
made on the design developed with George Malliaras. Chris Ober provided
general support and guidance.
This work is being submitted as an invited article to Biochimica et Biophysica Acta – General
Subjects. All figures reproduced with permission.
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5.2 Abstract
We report conducting polymer devices that alter the adhesion and secretion
characteristics of progenitor cells by controlling the conformation of surface-
adsorbed fibronectin and serum proteins. By using these devices to alter con-
formation in isolation (i.e., without changing matrix stiffness, composition, or
quantity), changes in protein conformation are shown to be responsible for the
upregulation of pro-angiogenic secretions from fibroblasts in the tumour envi-
ronment.
5.3 Introduction
The portion of tissues external to a cell, or the extracellular compartment, is
comprised of a matrix providing support and structure to the cellular compo-
nent of tissue. This extracellular matrix (ECM) is composed of fibrous proteins,
proteoglycans, and adhesive glycoproteins, as well as signalling molecules in-
cluding cytokines and growth factors [85]. By binding to, rearranging, and ap-
plying force to the ECM, cells are able to utilize the ECM as a signalling deposi-
tory. The main structural proteins within the ECM include collagen, fibronectin
(Fn ), elastin, and laminin, to which cells are able to bind at specific adhesion
sites [85]. The abundance of each specific protein type varies throughout the di-
verse tissues of the body (i.e., Fn is a major component of connective tissues and
is also found in the blood plasma [86]). Additionally, Fn is one of the two major
adhesive proteins in serum, making it one of the most widely utilized adhesive
proteins in cell culture [87].
60
In addition to the broad role Fn plays in the ECM, it is particularly known
to undergo changes within the tumour ECM [88]. During a process termed
desmoplasia, ECM synthesis in the tumour is enhanced, which leads to the de-
position of a thick protein matrix dense with Fn. This amplification of the Fn
content in the tumour as compared to normal epithelial ECM promotes tumour
progression [89], metastasis [88], as well as chemotherapeutic resistance [90]. Fi-
broblasts within the tumour microenvironment are largely responsible for these
changes to the tumour ECM [28]. In fact, Chandler et al. previously showed that
tumour-derived soluble factors cause fibroblasts to produce an ECM containing
Fn in a more extended conformation [69]. These changes in the tumour ECM
prompt questions regarding the role of this ECM protein in tumourigenesis.
The abundance of Fn in the ECM and in serum leads to its ubiquitous use in
cell culture, and thus a thorough understanding of how Fn signals various cellu-
lar functions is necessary. This large dimeric glycoprotein contains three types
of repeating modules which contain cell adhesion sites, such as the arginine-
glycine-aspartic acid (RGD) site as well as protein binding sites [91]. Cell adhe-
sion to Fn is largely mediated by the α5β1 integrin through the combination of
the RGD and synergy sequence sites [91]. While cells are able to actively reor-
ganize Fn in their ECM, this exceptionally extensible protein can undergo con-
formational changes that expose cryptic binding sites [22]. The conformation
of Fn can vary throughout the ECM and it is not fully understood how these
changes may alter cell behaviours. Fn can cause changes in the cell behaviour
not only because of altered cell binding as the protein conformation changes
but also due to changes in stiffness as changes in conformation also lead to al-
tered protein stiffness [22]. Various means including hydrogel artificial ECMs
have been implemented to investigate the role of stiffness in altering key cel-
61
lular functions including proliferation [92, 93], differentiation [94], malignancy
[95], and angiogenesis [96]; however, the ability to independently investigate
the role of protein conformation on these behaviours have been limited.
Many tumourigenesis-promoting processes are likely altered by changes in
Fn; in particular, one such process of paramount importance is the in-growth of
vasculature, as tissue survival and growth requires the ability to receive nutri-
ents and oxygen while disposing of unwanted cellular waste. tumours achieve
this through a process termed angiogenesis, which is reliant on a variety of pro-
angiogenic growth factors including vascular endothelial growth factor (VEGF)
[97]. As its name implies, VEGF directly impacts the function of endothelial cells
by promoting their ability to form the vasculature that enables tumourigenesis.
Here we present our investigation of the effect of altered tumour ECM structure
on the pro-angiogenic potential of tumour stromal cells. To this end, we cul-
tured fibroblasts in matrices derived from normal and tumour stromal cells and
quantified their pro-angiogenic potential by measuring VEGF secretion levels.
As changes to the ECM occur at sites of disease, means to decipher how these
changes contribute to disease progression are necessary. Diseased ECMs often
contain proteins in altered composition and conformation which can lead to
changes in both protein stiffness as well as overall tissue stiffness (Figure 5.1). To
decipher the role of ECM protein conformation independent of these other ECM
alterations on cell function, we utilized a conducting polymer device that we
previously showed could establish precisely-controlled protein conformations
over large areas [11]. Here, we take the next step by culturing cells on these
devices, allowing us to assess the isolated impact of ECM protein conformation
on the pro-angiogenic potential of tumour stromal cells. These findings stress
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Figure 5.1: Changes to the extracellular matrix (for example, in the tumour
microenvironment) lead to simultaneous changes in many ma-
trix properties, such as quantity, stiffness, composition, and
conformation. Traditional experiments using cell-derived ma-
trices are unable to isolate one experimental parameter, such
as conformation. By using a PEDOT:PSS conducting polymer
device (bottom), protein conformation can be controlled in iso-
lation, enabling studies of the role of altered conformation in
altered cell behaviour.
the importance not only of ECM content but also protein conformation.
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5.4 Results and Discussion
5.4.1 Tumour Stromal Cell-Derived Matrices Enhance Stromal
Cell Pro-Angiogenic Behaviours
Tumour-mimicking ECMs were produced by culturing 3T3-L1 cells for 3 days
in TCM or control media which as previously reported [69] produces matrices
with varying quantities of extracellular Fn (Figure 5.2A). These tumour and con-
trol cell-derived matrices were then isolated from the cells through a cell extrac-
tion process, maintaining the differential Fn (Figure 5.2B). Using these meth-
ods, the propagation of signals within the tumour matrix due to stromal cell
alterations to the matrix were measured. To assess changes in cell response to
the varying matrices, normal 3T3-L1 cells were reseeded onto the cell-derived
matrices and their pro-angiogenic capacity was quantified after 24 hours. Fi-
broblasts seeded onto tumour rather than control fibroblast-derived matrices
produce more VEGF, as measured via ELISA (Figure 5.2C).
5.4.2 Assessment of Altered Stromal Cell Secretions on En-
dothelial Cell Angiogenic Functions
We next investigated the response of endothelial cells to the altered pro-
angiogenic potential of stromal cells cultured on compact vs. unfolded ECM
protein conformation. We collected media after 24 hours from the 3T3-L1s that
were reseeded onto the cell-derived tumour and control matrices, and assessed
pro-angiogenic potential via a transwell migration assay with human umbilical
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Figure 5.2: 3T3-L1 cells produce a matrix of varied Fn content when cul-
tured in the presence of TCM [30]. The 3T3-L1 cells were
then extracted from these matrices leaving a cell-derived ma-
trix containing enhanced levels of Fn in the tumour condition
(A, scale bar = 10µm). When 3T3-L1 cells were subsequently
cultured on these matrices, more cells adhered to control as
compared to tumour-derived matrices (B). VEGF content in
the media from normal 3T3-L1 cells seeded onto these matrices
was greater for those cells on tumour as compared to control
3T3-L1-derived matrices (C).
65
Figure 5.3: Pro-angiogenic potential is assessed via a transwell migration
assay with HUVEC cells. Six times more HUVECs migrate
toward media from 3T3-L1s cultured in tumour conditions
as compared to the control. Representative micrographs are
shown at right (nuclei stained blue with DAPI, scale bar =
10µm.)
vein endothelial cells (HUVECs). As shown in Figure 5.3, six times more HU-
VECs migrated toward the tumour media, as compared to the control, confirm-
ing the increased pro-angiogenic potential of the stromal cell secretions cultured
in tumour-mimicking ECMs.
5.4.3 Assessment of the Role of Fn via pUR4 Peptide Inclusion
In agreement with previous findings [69], the TCM-treated 3T3-L1 cells pro-
duced an ECM containing elevated quantities of Fn. To further identify whether
Fn was a key regulator in the upregulation of VEGF secretion, pUR4 – a peptide
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previously reported to block Fn incorporation into the matrix [98] – was used
to produce Fn-null matrices. The addition of pUR4 inhibited Fn incorporation
into the TCM treated stromal cell matrices (Figure 5.4A) and while the increased
VEGF secretion by reseeded 3T3-L1 cells was still seen in the tumour condition,
those matrices lacking Fn did not produce significantly higher VEGF secretion
than controls (Figure 5.4B). The tumour ECM has long been known to contain
higher quantities of Fn [88], and while Fn has been shown to influence various
pro-tumourigenic functions including: angiogenesis [99], metastasis [100], and
drug resistance [101], we show that it may additionally contribute to changing
the local stromal pro-angiogenic behaviour.
5.4.4 Fn Conformation Alters Stromal Cell Pro-Angiogenic Be-
haviours
In addition to increasing Fn content in matrices, treatment of 3T3-L1 cells in
TCM was previously shown to increase the concentration of Fn in an unfolded
conformation within these matrices [69]. Accordingly, we continued by investi-
gating the role of Fn conformation in causing alterations to the pro-angiogenic
function of stormal cells. We hypothesized that the changes in Fn conformation
played a key role in altering the pro-angiogenic potential of the 3T3-L1s, and
we sought to isolate the effect of conformation from other potential variations
in the ECM with the use of a conducting polymer device. This device is capable
of establishing over a large area, any single conformation (or range of conforma-
tions) of adsorbed Fn from compact, to extended, to partially unfolded. Further,
this is achieved without the accompanying changes to mechanical stiffness or
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Figure 5.4: Matrices produced by 3T3-L1 cells in the presence of TCM (tu-
mour) show elevated Fn content which is no longer enhanced
when TCM is supplemented with the peptide (pUR4) that in-
hibits Fn incorporation into the matrix (A, scale bar = 20µm).
When normal 3T3-L1 cells are reseeded onto these matrices,
only the matrix produced in the presence of TCM alone results
in elevated VEGF secretions (B, * indicates p < 0.05).
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biochemistry (i.e., composition) that likely occur in a complete ECM [11].
We first coated our devices with Fn in serum-free media for one hour under
an applied bias of +1 V (1 V) to establish a compact (unfolded) conformation.
We then seeded 3T3-L1s on the prepared surfaces and collected their media af-
ter 24hours of culture to measure the amount of VEGF produced by cells on the
different conformations. We observed that fewer (25%) cells adhered to the un-
folded Fn as compared to the compact Fn (Figure 5.5A) the same behaviour ob-
served with the tumour ECMs as compared to the control ECMs (Figure 5.2A),
and in agreement with previous results that treatment of 3T3-L1 cells in TCM in-
creased the incorporation of Fn in an unfolded conformation [69]. We found that
cells cultured on our devices on unfolded Fn produced 40% more VEGF than
cells cultured on compact Fn (Figure 5.5B), thus confirming that the observed
changes in pro-angiogenic potential are linked to changes in Fn conformation.
We next repeated this experiment with serum-containing media (10% FBS) to
test this effect in conditions more relevant to typical cell culture. We coated our
devices with serum-containing media (no additional Fn) and subsequently cul-
tured 3T3-L1s on them, as before. Under serum conditions, we again observed
that fewer (40%) cells adhered to the unfolded Fn as compared to compact, and
that the cells cultured on the unfolded conformation again produced more (65%)
VEGF than those cultured on the compact conformation (Figure 5.5B).
We additionally investigated these effects with other cell types, including
human mesenchymal stem cells (hMSCs), a stem cell often studied for its role
in the tumour stromal compartment. We observed similar trends in VEGF pro-
duction on the compact and unfolded protein conformations (Figure 5.5C), sug-
gesting the applicability of these findings in a broader context of different, more
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Figure 5.5: Oxidized or reduced PEDOT:PSS surfaces were coated with
either fibronectin (Fn) only or 10% serum (containing Fn) in
medium for 1 hour prior to cell seeding. With both types of
coatings, Fn on the oxidized side assumed a compact confor-
mation while Fn on the reduced side assumed an unfolded
conformation. 3T3-L1 cells were seeded onto these surfaces,
and fewer cells adhered to the unfolded conformation (A, * in-
dicates p < 0.05 from matched compact conformation condi-
tion). The media from the 3T3-L1 cells seeded onto the sur-
faces was then analyzed via ELISA for VEGF content (B, * indi-
cates p < 0.05 from matched compact conformation condition),
showing increased secretion on the unfolded protein. Further
analysis of other cell types (human mesenchymal stem cells) in-
dicates similarly enhanced secretion of VEGF on the unfolded
protein following serum coating (C, * indicates p < 0.05 from
matched compact conformation condition). Neutralization of
the and β1 integrin subunit in the 3T3-L1 cells seeded onto the
Fn in a compact conformation lead to an increase in VEGF se-
cretion (D, white paired bars, * indicates p < 0.05). Meanwhile,
neutralization of the αv integrin subunit in 3T3-L1 cells resulted
in a decrease in VEGF secretion by these cells on unfolded con-
formation (D, black paired bars, * indicates p < 0.05). No
significant difference in VEGF secretion is seen between cells
seeded onto compact vs. unfolded Fn when both integrin sub-
units are neutralized (D, final paired bars).
70
human-relevant cell types.
With these results implicating the importance of Fn conformation, we inves-
tigated the mechanism behind this effect by studying the roles of α5β1 and αvβ3,
two of the main integrins responsible for cell-Fn binding [102]. One of the key
differences between the binding mechanisms of the two integrins is that α5β1
binding is conformation-dependent, whereas αvβ3 binding is not [102, 103]. The
α5β1 integrin simultaneously binds the arginine-glycine-aspartic acid (RGD) se-
quence and synergy site on the neighbouring III10 and III9 modules of Fn, re-
spectively [78]. As a result, extended and unfolded conformations would pro-
gressively increase the spatial separation between the RGD and synergy sites,
thus progressively inhibiting α5β1 binding. In these situations, cells might uti-
lize more αvβ3 integrins for binding, to compensate for the reduced engage-
ment of α5β1 integrins [102]. Indeed, increased engagement of αvβ3 (historically
known as the vitronectin receptor) has been linked to increases in VEGF pro-
duction [26].
To further test this hypothesis, we investigated the effect that blocking the
α5β1 and αvβ3 integrins would have on VEGF production levels. We first in-
hibited α5β1 with a β1 function-blocking antibody in cells seeded on prepared
serum-coated electrochemically-oxidized polymer devices where Fn was in a
compact conformation. We observed that VEGF levels were increased on the
compact Fn as compared to the control conditions with no antibody (Figure
5.5D, white paired bars). This suggests that these cells do increase VEGF pro-
duction through some means of decreased α5β1 utilization.
Next, we tested whether this increased secretion was due to a compensation
of αvβ3 in response to decreased α5β1 engagement. To this end αvβ3 was inhib-
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ited, by adding an αv function-blocking antibody to cells seeded on prepared
serum-coated electrochemically-reduced polymer devices where Fn was in an
unfolded conformation. Here, we observed that the typically enhanced VEGF
production on unfolded conformations was inhibited, and VEGF levels were
reduced back down to the levels observed on a control compact conformation
surface (Figure 5.5D, black paired bars). This further supports the hypothesis
that in the absence of any function-blocking antibodies, αvβ3 engagement is up-
regulated on unfolded ECM protein conformations, which leads to a concomi-
tant increase in VEGF production. This is in agreement with previous findings
showing that conformational changes in Fn control the specificity of integrin
engagement, specifically as a balance between αvβ3 and α5β1 usage [102].
Finally, we inhibited both α5β1 and αvβ3 simultaneously in cells seeded on
prepared serum-coated conducting polymer devices (with compact and un-
folded conformation surfaces). Here, we observed that the amount of VEGF
secreted by stromal cells on both the compact and unfolded conformation sur-
faces were not significantly different from the amount of VEGF produced on
a control compact surface (Figure 5.5D, final paired bars). This suggests that
VEGF secretion does not increase while αvβ3 is inhibited, regardless of whether
or not α5β1 is also inhibited. This is likely due to a compensation by the cell
to utilize αvβ3 when α5β1 engagement is inhibited either due to conformational
misalignment with Fn or due to function blocking antibodies. However, with
blockade of the αvβ3 integrin, the upregulation in VEGF secretion that would
result from increased αvβ3 integrin engagement is not achievable.
As a check, we verified that the measured differences in VEGF (shown in
Figure 5.5B and C) were due to changes in cell secretions, rather than differ-
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ential binding of VEGF to the altered conformations of fibronectin. We coated
oxidized or reduced PEDOT:PSS surfaces with 10% serum (containing Fn) in
medium for 1 hour to establish surfaces with altered Fn conformation. Then,
we incubated the prepared surfaces with medium containing a known concen-
tration of VEGF (150pg/mL) for 2 hours to allow VEGF to bind to the surface-
adsorbed Fn. After 2 hours, we collected the supernatant and measured the
VEGF content via ELISA. The amount of surface-adsorbed VEGF was calcu-
lated by subtracting from the initial concentration. As shown in Figure 5.6, 15%
more VEGF adsorbed to reduced surfaces (unfolded conformation). This is in
agreement with previous work showing increased VEGF binding to unfolded
Fn [104], and importantly, shows that the measured VEGF increase from cells
on reduced surfaces is indeed due to enhanced cell secretions.
5.5 Conclusions and Perspectives
These findings have significance for a broad range of areas from tissue engineer-
ing to cancer biology. While our previous work has shown the conformation of
Fn within in vitro tumour stromal cell matrices to be in a more unfolded con-
formation [69], we show here the significance of this conformational variability
in Fn on the pro-angiogenic capacity of a tumour. As stromal cells only con-
tribute in part to tumour angiogenesis, further work is necessary to understand
the role of altered Fn conformation on the tumour cells, as well as other cells
resident within the tumour microenvironment. Furthermore, as Fn and other
proteins assume altered conformations when in contact with various surfaces
[105], understanding how these conformational changes can alter cell functions,
such as angiogenesis, will both improve our understanding of cell-biomaterial
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Figure 5.6: Oxidized or reduced PEDOT:PSS surfaces were coated with
10% serum (containing Fn) in medium for 1 hour to estab-
lish surfaces with altered Fn conformation, and then incubated
with medium containing a known concentration of VEGF
(150pg/mL) for 2 hours to allow VEGF binding to surface Fn.
After 2 hours, the supernatant was collected and VEGF content
was measured via ELISA. 15% more VEGF was found to bind
to reduced PEDOT:PSS surfaces (unfolded conformation), as
compared to oxidized surfaces (compact conformation). * indi-
cates p < 0.05).




3D CONDUCTING POLYMER SCAFFOLDS FOR CELL CULTURE
6.1 Contributors
This project is a collaboration between the Ober, Fischbach, and Giannelis
groups. Lou Estevez (a graduate student in the Giannelis group) developed
the original idea for the project with me, and led the initial efforts to develop
3D macroporous PEDOT:PSS scaffolds. Lou passed the project on to Tiffany
Williams (a graduate student in the Giannelis group), who has been instrumen-
tal in optimizing the fabrication process, as well as characterizing the scaffolds.
Claudia Fischbach, Delphine Gourdon, George Malliaras, and Chris Ober have
provided useful suggestions in all experimental aspects of the project. Em-
manuel Giannelis has contributed to the preparation of the manuscript.
6.2 Abstract
We report three-dimensional macroporous scaffolds made from a conducting
polymer via ice-templating, that support live cell culture for upward of 7 days,
and provide electrical control over cell adhesion and pro-angiogenic poten-
tial. Such structures may serve as a model to understand and control three-
dimensional cell-surface interactions via electrical stimuli, with applications in
basic research, medical diagnostics, and tissue engineering.
This work is in preparation for submission.
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6.3 Introduction
Cell culture in two dimensions is convenient and can be well-controlled in the
laboratory environment, leading to the widespread use of petri dishes, tissue
culture flasks, and other planar substrates for cell culture. While 2-dimensional
systems offer the benefits of consistent, repeatable structures, and ease of use,
we must always be mindful that cells in vivo exist in a 3-dimensional microen-
vironment (even those cells that grow in monolayers), and that their behaviour
can be radically different due to the microenvironmental changes implicit in a
3-dimensional system [14, 106–108]. For this reason, much recent work has fo-
cused on developing 3-dimensional scaffold systems that can both support 3D
cell cultures and mimic in vivo tissue properties to some degree.
While many strategies for such structures exist, including hydrogels, elec-
trospun networks, and macroporous scaffolds of various kinds, all must be de-
signed with the ability to support cell attachment and allow for oxygen and
nutrient transport (diffusion).
With the goal of developing an electrically conducting 3D scaffold, we fab-
ricated 3-dimensional macroporous scaffolds made from PEDOT:PSS, yield-
ing an electrochemically-active device architecture capable of supporting 3-
dimensional cell culture. Using such scaffolds, we examined the behaviour of
cell adhesion and secretions in a 3D environment, as a function of the oxidation
state of the PEDOT:PSS scaffolds.
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Figure 6.1: As the suspension freezes, the growing solvent ice phase (blue)
confines dispersed particles (red) into the regions between ice
domains.
6.4 Ice Templating
Among the various methods that have been developed for preparing macrop-
orous scaffold-type structures, ice templating (freeze casting) has attracted con-
siderable attention due to its versatility and low cost. As shown schematically
in Figure 6.1, ice templating exploits spontaneous phase segregation during the
solidification of a suspension, leading to induced ordering of dispersed particles
that are confined to the regions between solvent crystals [109–112]. Subsequent
sublimation of the solvent ice phase leaves behind the solid scaffold structure
composed of the dispersed particles, which can be baked or sintered as required
to stabilize the structure.
To date, ice-templating work has emphasized suspensions of ceramic
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nanoparticles (occasionally with an organic binder) [110–113], with other work
focusing on scaffolds based on poly(vinyl alcohol) (PVA), poly(vinyl laurate)
(PVL), poly(lactic acid) (PLA), poly(acrylamide), and polystyrene (PS), either
with or without inorganic nanofillers (i.e., silica, ceria, clay, carbon nanotubes)
[114–118]. More recently, scaffolds with electronic and/or ionic conductivity
have been demonstrated, such as in the case of graphene/platinum/nafion hy-
brid scaffolds [119], and preliminary studies into sheet-like 3D structures of PE-
DOT:PSS [120].
6.5 Macroporous PEDOT:PSS scaffolds
Scaffolds were fabricated from an aqueous dispersion of PEDOT:PSS (PH-1000,
Heraeus) at a concentration of 1.25wt%, with 3-glycidoxypropyltrimethoxysilane
(GOPS) added as a crosslinker at 3 wt% to improve stability in water for long-
term cell culture. The PEDOT:PSS/GOPS solution was poured into rectangu-
lar teflon molds, 7 × 4 × 2 mm in size. The samples were then placed in a
freeze-dryer, where they were frozen from 5 ◦C to −40 ◦C at a controlled rate of
−0.9 ◦C/minute, after which the ice phase was sublimed from the scaffolds. Fol-
lowing sublimation, the scaffolds were baked at 140 ◦C to anneal the PEDOT:PSS
phase.
Mercury porosimetry revealed that the remaining PEDOT:PSS scaffolds
were highly porous, with a total pore area of 2.34m2/g and a median pore di-
ameter of 35µm (Figure 6.2). Pore volume was measured at upward of 98%,
confirming the porous, open structure of the scaffolds.
A dynamic mechanical analysis (DMA) instrument was used to measure
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Figure 6.2: Mercury porosimetry data for a PEDOT:PSS scaffold, yielding
a total pore area of 2.34m2/g and a median pore diameter of
35µm.
the elastic modulus of scaffolds made from PEDOT:PSS either with or with-
out 3 wt% GOPS, and in either dry or wet conditions (in αMEM cell culture
medium). Measurements were performed with a single loading cycle, with an
initial contact force of 0.05N and loaded at a fixed force-rate of 0.005N/minute.
A fixed force-rate was used rather than a fixed strain-rate, for reasons of better
control (as recommended by the manufacturer, TA Instruments). Typical force
curves obtained from the measurements are shown in Figure 6.3. Elastic modu-
lus was calculated as the slope of the linear part of the stress-strain curve near
zero strain. Dry scaffolds without GOPS were found to have an elastic modu-
lus of 360Pa, while wet scaffolds with 3 wt% GOPS had an elastic modulus of
750Pa, indicating good matches with the mechanical stiffnesses of a variety of
tissue types in vivo [121].
These values for both pore size and elastic modulus can be tuned by adjust-
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Figure 6.3: Representative force curves from a compression cycle, ob-
tained with a dynamic mechanical analysis tool, from a PE-
DOT:PSS scaffold with 3 wt% GOPS, submerged in αMEM.
Elastic modulus is calculated as the slope of the linear part of
the curves near zero strain.
ing the fabrication protocol. Lowering the freezing rate generally increases pore
diameter, which would be preferred for this application (pore sizes on the order
of 100µm to 300µm would be better for cell culture, similar to the pores found
in PLGA scaffolds used by the Fischbach group and others). Additionally, re-
ducing the amount of GOPS crosslinker would slightly increase the median pore
size.
6.6 Electrical Control of Cell Behaviour
Electrodes were attached to pairs of scaffolds, which were submerged in
electrically-grounded αMEM with 10% fetal bovine serum (FBS) and 1%
penicillin-streptomycin. A bipolar power supply sourced an oxidizing poten-
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tial of +1V to one scaffold, and a reducing potential of −1V to the other. The
bias was maintained for 1hour at 37 ◦C, after which the scaffolds were removed
from the electrodes and placed in individual wells of a 12-well plate. 3T3-L1
mouse preadipocytes were seeded at a density of 1.5 million cells in 30µL of
αMEM (containing 33% matrigel, to promote adhesion), and allowed to adhere
in an incubator for 30minutes. Fresh media was then added to the wells and
the plates were incubated on a shaker plate to promote media circulation for
oxygen/nutrient diffusion.
It should be noted that the use of matrigel often led to the formation of a
thick white layer (likely of collagen) at the top (seeding) surface of the scaf-
folds, even though the cell suspension (containing matrigel) was kept cold (on
ice) prior to seeding to prevent collagen polymerization. This collagen layer
made surface-characterization difficult (i.e., via SEM imaging). Seeding was at-
tempted in the absence of matrigel, but many cells flowed through the scaffold
and out onto the plate underneath, significantly lowering seeding density. Fu-
ture efforts should focus on seeding the cells with a lower amount of matrigel,
or in a smaller volume in the absence of matrigel, to mitigate these problems.
Cell behaviour was typically investigated after 24hours of culture (with the
exception of viability assays performed out to 7days of culture to verify the
long-term viability of cells cultured in such scaffolds). Scaffolds were rinsed in
PBS and soaked in 4% ice-cold paraformaldehyde for 45minutes for chemical
fixation.
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Figure 6.4: Cell number was quantified via fluorometric DNA assays. 50%
more cells adhered to oxidized (+1 V) scaffolds as compared to
reduced (−1 V) scaffolds. * indicates p < 0.05.
6.6.1 Cell Adhesion
Cell adhesion was quantified after 24hours of culture via a fluorometric DNA
assay, after the scaffolds were cut apart and their cells were lysed. Adhesion to
the oxidized scaffolds was stronger, with 50% more cells counted in oxidized
scaffolds as compared to reduced scaffolds (Figure 6.4).
Scaffolds were also prepared for scanning electron microscopy (SEM) to as-
sess and visualize cell infiltration of the scaffolds. After 24 hours of culture,
the scaffolds were chemically fixed as described above, and either rinsed in
PBS or DI water to remove excess formaldehyde. They were then placed in a
freeze-dryer to remove the water via sublimation (to avoid structural damage
from evaporation due to the high surface tension of water). The scaffolds were
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then microtomed at a shallow angle relative to the top face, to expose a range
of depths for imaging. After being coated with a conductive Au/Pd sputtered
layer, the scaffolds were imaged in an SEM.
Rinsing the scaffolds after chemical fixation in PBS retained cell integrity
(due to PBS being isotonic), but resulted in undesired salt crystals that were
visible in SEM images on some occasions. Salt crystals were not always visible,
however, as seen in the micrograph in Figure 6.5, showing successful intrusion
of cells into the scaffolds. The presence of salt crystals may have been mitigated
in this case by using a smaller volume of PBS for the final rinse just prior to
freeze-drying.
Rinsing in DI water removed any possibility of remaining salt crystals, but
resulted in undesired cell lysis (due to DI water being hypotonic); however, this
did enable imaging of cell-made protein fibers in the scaffolds (Figure 6.6) that
would otherwise have been obscured by the cells themselves. The size of the
fibers suggests that they are too large to be fibronectin, and may be made from
matrigel-derived collagen.
Fibronectin immunostaining of scaffolds after 24 hours of culture revealed
that fibronectin fibers are also present in the scaffolds (in addition to the fibers
observed via SEM that were likely collagen), as shown in Figure 6.7.
Viability assays were performed to investigate whether cells could survive
in the PEDOT:PSS scaffolds for long periods of time. To this end, cells were cul-
tured in scaffolds for up to 7 days (with media replacement every 2 days). After
7 days, a viability assay confirmed that the vast majority of cells at the scaffold
surface remained alive (Figure 6.8). Future imaging of a scaffold cross-section
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Figure 6.5: Scanning electron micrograph showing a PEDOT:PSS scaffold
after 24 hours of culture, infiltrated by 3T3-L1 cells that were
seeded with matrigel. Scale bar is 20µm.
Figure 6.6: Scanning electron micrographs taken after 24 hours of cell cul-
ture, showing protein fibers made by 3T3-L1 cells seeded with
matrigel into a PEDOT:PSS scaffold. Cells were lysed in a DI
water rinse prior to imaging, resulting in improved visibility of
the fibers. The fibers are likely too large to be fibronectin, and
are likely made from matrigel-derived collagen. Scale bars are
30µm.
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Figure 6.7: Fluorescence micrograph showing immunostained fibronectin
fibers (green) within a scaffold after 24 hours of culture. Nuclei
are stained with DAPI (blue) and dead cells are stained with
propidium iodide (red).
would provide useful information about viability throughout the scaffolds.
6.6.2 Pro-Angiogenic Potential
To assess changes in the pro-angiogenic potential of 3T3-L1 cells cultured in ox-
idized vs. reduced conditions, we measured the amount of VEGF secreted over
24hours via ELISA. We found that cells cultured in reduced scaffolds secreted 4
times more VEGF than those cultured in oxidized scaffolds (Figure 6.9. This is in
agreement with previous results (Chapter 5), where 3T3-L1 cells on reduced PE-
DOT:PSS surfaces (where surface-adsorbed fibronectin was electrochemically-
induced into assuming an unfolded conformation) also secreted more VEGF
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Figure 6.8: Fluorescence micrograph of a scaffold surface after viability
staining at t = 7 days. Live cells are stained with calcein (green),
and dead cells are stained with propidium iodide (red). The
pores of the scaffold are visible as large circular darkened re-
gions.
than those cultured on oxidized surfaces (with compact fibronectin).
Importantly, this is in agreement with previous results [69] showing that fi-
bronectin in the tumour microenvironment assumes a more unfolded confor-
mation as compared to healthy tissue. The observed up-regulated secretion of
the pro-angiogenic molecule VEGF in the 3-dimensional environment of the
PEDOT:PSS scaffolds implicates the role of protein conformation in the pro-
angiogenic reponse of cells in the tumour microenvironment.
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Figure 6.9: Four times more VEGF was secreted by cells cultured in oxi-
dized (+1 V) scaffolds as compared to reduced (−1 V) scaffolds.
* indicates p < 0.01.
6.7 Conclusions and Perspectives
We developed 3-dimensional macroporous scaffolds made from PEDOT:PSS,
which exhibit electrical conductivity, and possess mechanical stiffness values
that provide a good match with a variety of tissue types. 3T3-L1 cells were
successfully cultured in theses scaffolds, and remained viable for over 7 days
of culture. Additionally, electrochemical oxidation/reduction of the scaffolds
prior to cell-seeding allowed control over the subsequent adhesion and secre-
tions of 3T3-L1 cells cultured therein.
After 24 hours of culture, cells adhered in greater numbers (50% more) in
oxidized scaffolds as compared to reduced scaffolds, and levels of secreted
VEGF were 4 times higher in reduced scaffolds as compared to oxidized scaf-
folds. These trends recapitulate both the redox-dependent adhesion and secre-
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tion behaviours observed in 2-dimensional thin-film systems, but appear to be
enhanced in magnitude.
These results demonstrate the suitability of ice-templated macroporous PE-
DOT:PSS scaffolds for 3-dimensional cell culture experiments under electro-
chemical stimuli. Models could be developed for a variety of tissue types with
stiffnesses ranging from ∼0.1kPa to 10kPa, owing to the simple adjustability
of scaffold stiffness (by varying the amount of crosslinker). Using this scaffold
architecture for mono- or even co-cultures of different cell types could enable
interesting 3-dimensional studies of cell behaviour as a function of local protein




The work presented in this dissertation centred around the use of
two variants of the conducting polymer poly(3,4-ethylenedioxythiophene):
one doped with p-toluenesulfonate (PEDOT:TOS) and one doped with
poly(styrenesulfonate) (PEDOT:PSS) as presented in Chapter 1. This organic
electronic material was used at the interface with proteins and live cell cul-
tures in two different architectures – as planar thin-film devices, and as three-
dimensional macroporous scaffolds. Results were presented demonstrating the
electrochemically-mediated control of cell adhesion, cell motility, protein con-
formation, and pro-angiogenic cell secretions. This work establishes the use of
this class of organic electronic materials as active interfaces for cell studies, and
points toward many possible interesting extensions and areas for future inves-
tigation.
Cell Adhesion
In Chapter 2, a simple planar device was introduced based on thin films of PE-
DOT:TOS. Applying a linear voltage gradient from +1V to −1V established a
semi-permanent redox gradient in the PEDOT:TOS film which remained after
the bias was removed. Two different types of cells (3T3-L1 mouse fibroblasts
and MDA-MB231 human breast cancer cells) were cultured on these surfaces
and their adhesion characteristics were evaluated.
Cell adhesion was modulated for both 3T3-L1s and MDA-MB231s, and
quantified in terms of the local density of cells as a function of applied redox
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potential. In both cases, cell density gradients were established, with large
numbers of cells (at densities reaching those of confluent monolayers) on the
oxidized and neutral regions of the PEDOT:TOS films, and increasingly fewer
cells toward the reduced end of the film. Thus, this device demonstrates the
ability to spatially control cell adhesion with an electrical stimulus.
It is worth noting that while both cell types tested in these experiments ex-
hibited the same adhesion characteristics, finding two cell types that adhered
preferentially to opposite redox states (for example, as demonstrated for MDCK
cells by Bolin and coworkers [122]) could enable interesting cell-sorting capabil-
ities.
Cell Motility
In Chapter 3, the same planar PEDOT:TOS thin-film device described in Chap-
ter 2 was used to investigate electrical control over cell motility. Bovine aortic
endothelial cells (BAECs) were cultured along a PEDOT:TOS stripe which had
been pre-biased with a linear voltage gradient. When the BAECs were observed
over a period of six hours, marked differences were observed in their migration
behaviour on oxidized vs. reduced regions of the polymer. In terms of both
migration speed and persistence time, a 3-fold increase was observed on the
most oxidized regions of the polymer as compared to the most reduced regions.
Thus, this device demonstrates the ability to control the migration characteris-
tics of cells, in addition to the spatial control over cell adhesion demonstrated in
Chapter 2.
It is worth noting that although persistence time was substantially increased
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on oxidized surfaces, cells did not migrate in a preferential direction with re-
spect to the electrochemical gradient (i.e., toward either the oxidized or reduced
end). This is likely because the slope of the gradient is too weak to be noticeable
on the length-scale of a single cell: a gradient of ±1 V over a length of 2 cm (an
electric field strength of 1V/cm) translates to an equivalent potential drop of
2mV across a 20µm-wide cell. Such a small potential difference likely results in
virtually undetectable differences in the oxidation state (or surface energy, pH,
etc.) of the polymer substrate, thus preventing the likelihood of directed cell
migration.
With the powerful repertoire of available lithographic techniques, much
smaller PEDOT:TOS channels could be created to enable significantly stronger
electric fields without exceeding the ∼1.3V potential barrier (with respect to
the electrolyte) beyond which undesired electrolysis of the electrolyte would
occur. Sufficiently strong electric fields could establish a steep enough redox
gradient that would be detectable by single cells. Such conditions would likely
result in directed cell migration along the direction of the gradient (either par-
allel or anti-parallel) on oxidized surfaces, where persistence time is elevated.
This could enable interesting cell-sorting capabilities, if different cell types are
found to migrate at sufficiently different speeds.
Fibronectin Conformation
In light of the results presented in Chapters 2 and 3, we sought to investigate the
biological mechanism by which the altered local redox state of a PEDOT:TOS
substrate was affecting cell adhesion and motility. Owing to the critical role
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played by adhesion proteins in cell-substrate adhesion characteristics, we chose
to investigate the role of fibronectin, an adhesion protein of known importance.
Initial studies of differential Fn (mass) adsorption via immunostaining and XPS
were inconclusive, so we proceeded to study Fn molecular conformation via
Fo¨rster Resonance Energy Transfer (FRET) studies.
In Chapter 4, two variants of the PEDOT:TOS thin film device used in
the preceding cell adhesion and secretion studies were used to investigate the
molecular conformation of fibronectin molecules that were adsorbed under an
applied bias. Under a potential gradient from +1V to −1V, Fn conformation
was found to vary monotonically and gradually from compact, through ex-
tended, to partially-unfolded. This monotonic relationship between FRET ratio
(and therefore, Fn conformation) and applied bias gives, in essence, a calibra-
tion curve that conveniently maps any desired conformation to a corresponding
electrical potential.
Using a modified device architecture with two large pixels (rather than a sin-
gle connected stripe), single conformations were established across entire pix-
els. This enables cells to be cultured on a surface with a precisely-defined fi-
bronectin conformation, allowing definitive studies of cell behaviour as a func-
tion of protein conformation. To this end, 3T3-L1s were cultured on oxidized
and reduced PEDOT:TOS pixels with compact and unfolded fibronectin, respec-
tively. More cells adhered to the oxidized pixels (with compact Fn) as compared
to the reduced pixels (with unfolded Fn). Further, when a function-blocking an-
tibody was introduced to block usage of the α5β1 integrin, cell numbers equal-
ized on the compact and unfolded conformations. This implicates the role of
the α5β1 integrin in conformation-dependent cell adhesion, providing a biolog-
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ical mechanism underlying the adhesion and motility characteristics observed
earlier (since motility is intimately related to strength of adhesion).
Importantly, mechanical stiffness of the protein-coated surfaces was un-
changed regardless of oxidation state, indicating that such devices control pro-
tein conformation in isolation, without associated changes to mechanical prop-
erties or biochemistry.
Conformation-Mediated Pro-Angiogenic Potential
The ability to control protein conformation as an isolated parameter was ex-
ploited in Chapter 5 to study protein conformation-mediated pro-angiogenic
potential in stromal cells, in a way that is inaccessible to traditional experiments.
Previous work by Chandler and coworkers [69] showed that fibronectin fibers
were altered in the tumour environment, where they exhibited a more extended
conformation and higher mechanical stiffness than fibers produced in healthy
tissue. Since tumours are associated with increased pro-angiogenic activity, we
sought to investigate the role played by fibronectin in this process.
Using cell-derived matrices produced in tumour and normal conditions, al-
terations to fibronectin were implicated in the increased pro-angiogenic poten-
tial of 3T3-L1s cultured in a tumour environment; however, the specific role
of altered (extended) conformation could not be isolated from changes to pro-
tein quantity (increased) and matrix stiffness (increased). Thus, devices with
PEDOT:PSS pixels were used to establish surfaces with adsorbed proteins (in-
cluding fibronectin) in compact (control) and unfolded (tumour) conformations,
while maintaining stiffness and the concentration of the coating solution (it is
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not clear whether differential mass adsorption occurs. A definitive answer could
be obtained by employing a Quartz Crystal Microbalance to measure mass di-
rectly, or perhaps more simply with singly-labeled fluorescent fibronectin to
measure molecular density directly).
By culturing large populations of 3T3-L1s on the prepared pixels and
measuring the amount of secreted VEGF in the supernatant after 24 hours,
the role of altered fibronectin conformation was confirmed in increasing pro-
angiogenic potential. Additionally, integrin blocking experiments revealed the
conformation-dependent mechanism by which VEGF production is affected.
By blocking the α5β1 and αvβ3 integrins separately, and simultaneously, we ob-
served that unfolded fibronectin inhibited α5β1 binding, which caused a com-
pensatory increase in αvβ3 binding (and increased levels of αvβ3 are linked to
increased VEGF production).
3D Macroporous PEDOT:PSS Scaffolds
With all of the previous results coming from 2-dimensional thin-film device
studies, we sought to develop a similar electrically-active cell culture system
that could provide the increased physiological relevance of a 3-dimensional en-
vironment. In collaboration with the Giannelis group, we developed a method
to produce macroporous PEDOT:PSS scaffolds via ice-templating.
In Chapter 6, scaffolds were produced with control over pore size and me-
chanical properties, and were found to be biocompatible and to support viable
3T3-L1 cultures for upward of 7 days. Entire scaffolds could be oxidized (+1V)
or reduced (−1V) in media for 1 hour prior to seeding cells, allowing adhesion
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and secretions studies to be performed similar to those reported in Chapters 2
and 5, respectively.
Cell adhesion was quantified after 24 hours of culture by cutting apart the
scaffolds and lysing the cells in it to release their DNA into solution. The to-
tal amount of DNA was measured with a fluorometric DNA assay, allowing
quantification of the total number of cells in each scaffold. Oxidized scaffolds
contained 50% more cells than reduced scaffolds, suggesting that the adhesion
trends observed in Chapter 2 in 2D are recapitulated in the 3D environment as
well.
Presumably the differences in cell adhesion are due to differences in protein
(fibronectin) conformation, as observed in the 2D thin-film system. FRET stud-
ies were not conducted to verify this due to the expense of the experiment in
terms of the large volumes of FRET-labeled Fn that would be required (and that
were not available at the time). With some system optimization, the required
volume could be reduced to a more reasonable level, which should theoreti-
cally enable experimental confirmation that protein conformation is altered on
the 3D scaffold surface as it is on 2D films. The curvature of the scaffold pores
would somewhat complicate the FRET imaging process, but acquiring images
with sufficiently large regions in focus should be possible.
It is worth noting that the voltage-dependent conformation of adsorbed pro-
teins may well be similar to that found in the 2D film system of Chapter 4 due to
the relatively large radius of curvature of the pores (R ∼ 10 s to 100 s of µm) with
respect to the size of the adsorbed protein molecules (10 s of nm). Hence, on the
local scale of a protein molecule, the majority of a pore surface is likely to be
effectively 2-dimensional, with smaller pore edge and protrusion features pos-
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sibly having a small enough radius of curvature that they might substantially af-
fect fibronectin conformation. A careful FRET study could investigate whether
such a geometrical/topological effect exists with regard to the different-sized
features found in a scaffold.
Cell secretions from 3T3-L1s were evaluated by measuring VEGF content
(via ELISA) in the supernatant collected from scaffolds cultured for 24 hours.
Cells in reduced scaffolds secreted substantially more (4 times more) VEGF than
those cultured in oxidized scaffolds. This matches the trend observed in Chap-
ter 5 in the 2D thin-film system, but the increase observed in 3D is much more
pronounced. It is unclear at this time why the increase is so much larger in 3D,
but may be related to increased cell-cell contact (due to the nature of the 3D
environment, as well as a potentially higher cell density).
The conducting polymer scaffold system presented here offers potential for
further studies into cell behaviour (i.e., differentiation, proliferation, etc.) as a
function of protein conformation (via oxidation state) in a 3-dimensional envi-
ronment. The mechanical stiffness measured for the scaffolds matches well with
the moduli of a variety of soft tissues in vivo [121]. Further tuning of pore size
is required, however, with the goal to increase the mean pore diameter from
∼40µm up to 100 − 400µm (to better match the pore sizes found in the well-
studied gas foaming particulate leaching PLGA scaffold system [123]).
This can be achieved via three separate strategies: by lowering the ratio of
cross-linker (3-glycidoxypropyltrimethoxysilane, GOPS) to PEDOT:PSS in the
scaffold, by lowering the overall concentration of the solution from which the
scaffolds are freeze-casted, and by decreasing the rate of cooling during the
freeze-casting step.
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The current amount of crosslinker (3% by weight in the casting solution) is
unnecessarily high for the intended purpose of providing long-term stability in
an aqueous environment – a recent test showed that scaffolds produced with
0.125% GOPS were stable in cell culture medium for 24 hours with no apparent
degradation, although they showed significantly more electrochemical degra-
dation when under an applied bias. A GOPS concentration closer to 1% by
weight should provide sufficient electrochemical (and aqueous) stability, while
increasing pore size slightly.
Pore size can also be increased by diluting the starting solution to a lower
overall concentration. The stock PEDOT:PSS solution is purchased at 1.25% by
weight in water, to which GOPS can optionally be added. Diluting this solution
with water should yield final scaffolds with larger pores, although likely with a
concomitant decrease in mechanical stiffness. If the resulting stiffness was un-
desirably low for the application at hand, increasing the GOPS content should
raise stiffness considerably without entirely offsetting the increased pore size
due to the dilution.
Finally, pore size can be further tuned by adjusting the freezing conditions
during the freeze-casting process. A slower freezing rate (lower than the current
−0.9 ◦C/minute) should produce larger pores, and is easily controlled by the
freeze dryer. All of the three strategies presented above are currently being
investigated, and further study should yield protocols to produce scaffolds with
any desired pore size and elastic modulus.
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Final Perspectives
Opportunities exist to better characterize the materials property changes that
occur in the PEDOT systems under electrochemical oxidation and reduction, in
particular regarding the temporal dependence of many of the property changes
observed.
For example, surface energy in thin films was measured via water contact
angle in Figure 1.6, several hours (in air) after electrochemical oxidation/reduc-
tion. While this change in redox state appears to be relatively permanent in
air (on the time-scale of months to years, as assessed by eye due to the pho-
tochromic change), it is much less permanent in solution where it appears to
dissipate over the course of days. It would be interesting to investigate the
time-dependent evolution of the water contact angle due to immersion in an
aqueous medium. This could yield interesting materials science information,
although it is worth noting that in the context of cell culture, the chemical/en-
ergy properties of the surface are likely of significantly decreased importance
once the surface has been coated with cells that then produce a (microns) thick
protein matrix.
Similarly, surface pH changed with redox state as measured (in solution)
in Chapter 4. The change is likely due to the expulsion of protons from the
oxidized film (thus deprotonating the sulfonic acid groups in PSS or TOS and
lowering pH), and the reverse for the reduced film. It would be worth inves-
tigating the time dependence of this chemical change after immersion in cell
media, and additionally, measuring the actual local pH at the surface of the film
(both during and after the applied bias) would be challenging but could yield
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useful information.
Further, detailed characterization of the precise nature of the chemical
change in PEDOT is required. While the sulfonic acid moiety is almost cer-
tainly responsible for the pH change, it is important to understand the chemical
change in greater detail (and to determine if other mobile species from solu-
tion become present in the film). Understanding this could allow the rational
design of surfaces via chemistry alone, that could exhibit the same cell-altering
properties while avoiding some of the technical complications introduced by
the need for an external electrical circuit. While the conducting polymer system
was certainly needed for the gradient configurations presented in Chapters 2–4,
it offers no significant benefit over chemical functionalization for the pixel con-
figuration presented in Chapter 5 other than reversibility, which has not been
successfully utilized to date. Therefore, future studies utilizing functionalized
surfaces (without the need for a gradient) could benefit from the greater control
and variety offered by chemical functionalization.
One area of great interest to many who have seen the work in Chapter 4 is
the dynamics of protein folding on the surfaces presented here. Information on
both the time-scale and reversibility of conformational changes would be very
interesting, and in theory should be obtainable. In practice, the experiment in-
volves pseudo-real-time FRET measurements during reversible electrochemical
oxidation/reduction, and it has proven to be extremely difficult. Briefly, a two-
pixel thin-film sample is mounted onto a coverslip with an electrolyte solution
containing FRET-labeled Fn, and is placed on a confocal microscope for imag-
ing. The device is simultaneously connected to an external voltage source via a
single-pole, double-throw switch, which allows the polarity of the circuit to be
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rapidly reversed. A sufficiently slow scanning speed is selected on the micro-
scope such that a single image takes on the order of 1–2 minutes to fully raster
line-by-line. During the acquisition of the image, the polarity of the circuit can
be switched as desired, and FRET values can theoretically be calculated as a
function of time from the known scan-speed. Currently, there exists too much
intensity variation within a single field of view (due to sample-tilt, etc.) to ex-
tract believable FRET data. With optimization, however, this could prove to be
fruitful.
In all, the work presented in this dissertation represents an initial inves-
tigation into the ways that organic electronic materials can be used to influ-
ence and study the behaviour of cells and proteins in response to electro-
chemical stimuli. The results demonstrate the ability to direct the molecu-
lar conformation of surface-adsorbed proteins, and to use such surfaces to af-
fect cell adhesion, motility, and pro-angiogenic potential. Initial findings point
to changes in surface properties (surface energy, chemistry and pH, short-
range charge) that affect the conformation of protein molecules, and specific
conformation-dependent integrin binding mechanisms that subsequently affect
cell behaviour. These results suggest that such devices may serve as a platform
to study more complex biological phenomena, and a greater (characterization)
understanding should enable more variable and finely-tuned surfaces.
Additionally, there is immense potential to utilize the significant capabilities
of lithographic patterning in conjunction with such systems, to enable precise
studies on the length-scale of cells that have not been previously possible. In
particular, the promise of biologically-benign Orthogonal lithographic process-
ing points to many new possibilities that could involve an indefinite number of
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lithographic steps.
Further, as polymer systems can take many forms (such as macroporous
scaffolds, electro-spun networks, hydrogels, etc.), the potential to develop
“smart” cell-culture environments in the increased physiological relevance of
three dimensions is very promising, and likely represents the next major area of
development in this field of research.
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APPENDIX A
MULTICOMPONENT CELL PATTERNING WITH
PHOTOLITHOGRAPHY
A.1 Contributions
This project was a collaboration between the Ober and Fischbach groups. Youy-
ong Xu (former postdoctoral research associate in the Ober group) and Yosuke
Hoshi (former visiting scientist in the Ober group) developed the chemistry for
the photoremovable polymer brush. Yosuke synthesized brush samples for me
to use. David Infanger (postdoctoral research associate in the Fischbach group)
provided invaluable discussions and expertise in the early design stages of the
project to refine the choice of cell lines and relevant antibodies.
A.2 Introduction
Photolithography is a mature field with well-developed techniques for pattern-
ing substrates on the micrometre and nanometre scale. There are tremendous
opportunities to adapt photolithographic techniques for use in biological re-
search, where they could enable precise patterning of biological molecules (e.g.,
proteins) and cells. Existing methods for micron-scale (and sub-micron-scale)
biological patterning are based on protein patterning by way of techniques such
as parylene lift-off masks [124], micro-contact printing [125, 126], nano-imprint
This work went unfinished because of a lack of samples. The M.S. student who was hired to
learn the synthesis ultimately never produced any samples, which effectively killed the project.
102
lithography [127, 128], and biologically-benign lithography (i.e., with Orthogo-
nal (nano-imprint) lithography and fluorinated solvents).
Challenges exist with regard to the existing techniques: Parylene lift-off
masks can create very clean patterns of a single protein on the length-scale of
tens of microns, but lift-off is difficult with micron-sized features or smaller, and
patterning multiple protein types is not possible; Micro-contact printing pro-
vides the possibility of multicomponent protein patterning, but is dependent
upon adhesion of the proteins to the PDMS stamp; Finally, traditional nano-
imprint lithography cannot be used for multicomponent protein patterning due
to its reliance on harsh chemistries and plasma etching that would damage ad-
sorbed proteins during subsequent patterning steps.
The use of biologically-benign solvents and chemistries in Orthogonal pro-
cessing (or in nano-imprint lithography) presents possibilities for accurate mul-
ticomponent protein patterning at any desired length scale. This has been
shown by Priscilla Taylor and coworkers for nano-imprint lithography, and is
as-yet unproven for Orthogonal photolithography (although discussions with
Carol Newby have suggested it should be possible). In both of these cases,
however, while protein patterning should be achievable, subsequent cell pat-
terning would not be possible without additional work to functionalize the un-
patterned regions of the substrate with anti-fouling properties to prevent non-
specific adhesion of cells.
The work presented in this Chapter represents an alternative method for
multicomponent protein patterning using photolithography, with the added
benefit of retaining anti-fouling functionality on the un-patterned regions of
the substrate. This strategy utilizes an anti-fouling, photoremovable polymer
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brush, which is shown to enable multicomponent antibody patterning on a sin-
gle surface, and subsequent multicomponent targeted capture of live cells from
solution.
Successful completion of this work would represent the first demonstration
of a surface capable of selectively capturing multiple cell types from a single
solution onto precisely-patterned regions of the substrate. This would enable
complex studies of the interactions between multiple cell types, as a function of
cell colony size and their separation distance. Studies of this type have are not
possible at present, and could provide a powerful tool to the biological commu-
nity for precise micron-scale experiments in co-cultures.
A.3 Photoremovable Polymer Brush
A photoreactive surface-initiated atom-transfer radical polymerization (SI-
ATRP) initiator was deposited onto glass substrates and an anti-fouling poly-
mer brush was prepared on it. The SI-ATRP initiator contains a photo-cleavable
group, which adds photoreactivity to the polymer brush itself. The brush was
removed in specific regions by UV lithography to enable antibody adsorption
in the exposed areas.
A.3.1 SI-ATRP Initiator
The synthesis of the SI-ATRP initiator is shown in Figure A.1. To immobilize the
photoreactive initiator on glass substrates, glass microscope slides were treated
with a piranha solution (H2SO4/H2O2 (7:3 v/v)) at 60 ◦C for 30 min. The sub-
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Figure A.1: Preparation of photoreactive SI-ATRP initiator (1).
(a) BrCH2CH2OH, K2CO3, CH3CN. (b) 2-Bromoisobutyl
bromide, triethylamine, CH2Cl2. (c) HNO3, H2SO4, AcOH.
(d) NaBH4, THF-H2O. (e) Allylisocyanate, DMAP, CH2Cl2.
(f) Dimethylchlorosilane, Pt(C), CH2Cl2. Figure prepared by
Youyong Xu and reproduced with permission.
strates were washed with water and 2-propanol, blown to dry and dried in an
oven (100 ◦C) for 1 h. After cooling to room temperature under N2, the sub-
strates were soaked in a solution of toluene solution of 1 (0.2M, 0.1mL), tri-
ethylamine (0.03mL) and anhydrous toluene (10mL) overnight under N2. They
were then washed with CH2Cl2 and water, sonicated in CH2Cl2 and soaked in
CH2Cl2 for 1 day. The substrates were blown dry and used for the polymeriza-
tion reaction.
A.3.2 Preparation of PSBMA Brush
The PSBMA brush was prepared using a reported procedure [129] with some
modification. The initiator-immobilized glass substrate was placed in a flask.
105
CuBr (28.5mg, 0.2mmol) and CuBr2 (4.2mg, 0.02mmol) were placed in a round-
bottomed flask. SBMA (1.40g, 5mmol) and 2,2’-bipyridyl (68.1mg, 0.44mmol)
were placed in another round-bottomed flask. All flasks were pumped and
purged with N2 3 times. N2 bubbled MeOH (15mL) and water (7.5mL) were
added into SBMA/2,2’-bipyridyl, and the resulting solution was added into
CuBr/CuBr2. This mixture was stirred vigorously for 5min and then added
into substrate. After 12–30 min, the substrate was taken from the solution,
washed with water and soaked in hot water (50 ◦C) for 30 min. The substrate
was washed with water and 2-propanol and blown dry.
The thickness of the resulting brush was measured via ellipsometry to be
23nm. Under 365nm UV irradiation for 15 hours in PBS, the thickness is re-
duced to 1.7nm. The photoreaction is shown in Figure A.2.
A.4 Antibody Patterning for Live Cell Capture
The goal of the experimental design was to perform targeted capture of hu-
man cardiac microvascular endothelial cells (hCMECs) and tumour stem cells
(TSCs), in order to study potential pro-angiogenic behaviours induced in the
hCMECs by the nearby presence of TSCs. To achieve this, dual antibody pat-
terning was attempted with anti-CD31 (an antibody specific to the CD31 marker
of endothelial cells) and anti-SOX2 (an antibody specific to the SOX2 marker of
cancer cells).
Patterning was achieved by first exposing the PSBMA brush to 365nm UV
light (at 4mW/cm2) for 15 hours in PBS, using a test-pattern shadow mask.
This exposed amine groups in the patterned areas, while maintaining the anti-
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Figure A.2: SI-ATRP initiator and photoreaction of photo-removable poly-
mer brush. Under UV irradiation, the brush is cleaved at the
photo-sensitive ortho-nitrobenzyl (ONB) group. Figure pre-
pared by Youyong Xu and reproduced with permission.
fouling brush in unpatterned areas. The substrates were incubated in a solution
containing the appropriate antibody and then optionally stained for visualiza-
tion with a fluorescent secondary antibody. Patterning of both the CD31 and
SOX2 antibodies were successful, as shown in Figure A.3.
Subsequent patterning steps could be achieved by repeating the exposure
process with a different (or shifted) mask. The first layer of antibodies is kept
hydrated in PBS and shielded from UV by the mask, and so is able to main-
tain its biological function. In this way, dual (protein) patterning on a single
substrate was demonstrated by Yosuke Hoshi (Figure A.4).
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Figure A.3: Fluorescently-stained anti-CD31 (top) and anti-SOX2 (bottom)
antibody patterns on glass substrates. Line and square pat-
terns are transfered with good fidelity in a variety of pH con-
ditions. Some scratches are noticeable, likely due to damage
during handling which removed the anti-fouling brush from
those areas.
After each antibody was patterned onto a separate glass substrate, the sub-
strates were incubated in a solution of the appropriate cell-type (hCMECs for
CD31 and TSCs for SOX2) for 24 hours. The samples were then stained with
a secondary antibody for the surface-adsorbed antibody (CD31 or SOX2), and
a different secondary antibody for the captured cells. A representative image
is shown in Figure A.5, demonstrating successful targeted capture of hCMECs
from solution onto an array of 100µm squares.
The patterned anti-CD31 was also demonstrated to successfully capture hu-
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Figure A.4: (a) Dual colour fluorescence microscope image of patterned
DNP-BSA and anti-human IgG1 mouse antibody detected
with fluorescently-labeled antibodies and (b) their intensity
profiles on the dotted line. The green line shows the fluo-
rescence intensity of the green fluorophore-labeled anti-DNP
rabbit antibody and the orange line shows that of the orange
fluorophore-labeled anti-mouse rabbit antibody. Scale bar =
10µm.
man umbilical vein endothelial cells (hUVECs), as shown in Figure A.6.
While anti-SOX2 patterning was successful, as shown in Figure A.3, surface-
capture of TSCs proved difficult. This was in no small part due to the fact that
TSCs are a non-adherent cell-type, and grow in suspension. This was a fact I
was unaware of when designing the experiment, and added an obvious com-
plication to the goal of capturing cells on the substrate surface.
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Figure A.5: Fluorescently-stained hCMECs (green) are seen to preferen-
tially adhere to 100µm square patterns of anti-CD31 (red). Ad-
hesion to the smaller 50µm patterns is less successful (left),
and undesired adhesion to scratches in the anti-fouling brush
are seen at top and bottom left.
A.5 Conclusions and Perspectives
The completed experiments outlined above indicate that the goal of multicom-
ponent cell patterning is likely achievable, and it is rather unfortunate that the
project was not completed.
The choice of tumour stem cells was not ideal, as they grow in non-adherent
conditions and it was difficult to capture reasonable numbers of cells at the sur-
face. Rather than experiment with novel seeding conditions such as extremely
high concentrations of cells, or low-speed centrifugation, in order to attempt to
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Figure A.6: Fluorescently-stained hUVECs (green) are seen to preferen-
tially adhere to the cross pattern of anti-CD31 (red). An insuf-
ficiently high seeding density led to low numbers of adhered
cells, and undesired adhesion to scratches in the anti-fouling
brush are seen at top left. Some cells are also seen adhering to
the brush at lower-right, suggesting that the anti-fouling prop-
erties of the brush could be more potent.
capture more cells, it would likely be easier to simply select an adherent tumour
cell-line. So long as that cell-line exhibits cell-surface markers for which there
exist appropriate antibodies, it should function as desired from a patterning per-
spective and still offer an interesting biological interaction with endothelial cells
to study.
Admittedly, the materials system is far from ideal. The anti-fouling prop-
erties of the brush were only borderline-sufficient, with small but finite num-
bers of cells adhering to some areas of the unexposed brush (Figure A.6). The
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brush was also mechanically fragile and was easily scratched during the pat-
terning process, although this may be difficult to fully address (or “fix”) from
a chemistry perspective. The scratched regions naturally lost their anti-fouling
properties, which further led to cell adhesion in undesired regions.
Perhaps the greatest drawback of the current system is the unwieldy and
lengthy patterning process. Since the photocleaving reaction needs to take place
in an aqueous environment, samples cannot be exposed in an instrument such
as the ABM Mask Aligner. This means mask alignment is done by hand, and is
necessarily imprecise. While I believe some tricks can be played to achieve pre-
cision within 100µm, this is still a non-starter for precise, directed patterning.
My solution was to intentionally design two masks with a gradually-varying
relative offset between adjacent patterns, such that no matter what the relative
placement of the two masks on the substrate, there would be a high probability
that the desired pattern spacings would be found somewhere on the substrate.
The second problem is the extremely long exposure time of ∼15hours when
using our laboratory UV lamp, due in large part to the apparent low sensitiv-
ity of the photoactive group. A higher-power lamp might help mitigate this
somewhat, but clearly an exposure time counted in numbers of hours requires
serious optimization for to be adapted for more practical usage.
These various drawbacks notwithstanding, I still believe that this system, or
an improved/optimized version of it, can achieve live-cell capture of multiple
cell types onto precisely-patterned features. I believe this would represent an
important contribution to the biological community, as I am unaware of any ex-
isting technique or technology that can enable the precisely-controlled multiple
cell-type studies that should be possible with this system. An unoptimized sys-
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tem could certainly produce results worthy of a high-impact publication, but
its utility for others would likely be limited without improvements to the brush




B.1 Notes on PEDOT:TOS vs. PEDOT:PSS
The motivation for choosing PEDOT:TOS over the more conventional and pop-
ular PEDOT:PSS was somewhat historical in origin. When this work first be-
gan (circa 2007), PEDOT:TOS offered higher reported conductivities than PE-
DOT:PSS in thin-film form, offered better stability in aqueous environments,
and also had the benefit of being a vapour-phase technique, enabling the possi-
bility of creating complex conducting architectures in a non-line-of-sight man-
ner.
At present (2012), PEDOT:PSS has advanced to the point that commercially-
available PEDOT:PSS (PH-1000, Heraeus) can routinely achieve conductivities
in excess of 1000 S/cm with appropriate additives (DBSA, ethylene glycol), a
value several times higher than what is achievable with the PEDOT:TOS mate-
rials and methods used for this work. Additionally, crosslinking additives such
as GOPS can impart remarkable stability to PEDOT:PSS films in aqueous envi-
ronments, exceeding the stability of PEDOT:TOS films (particularly under the
destabilizing conditions of electrochemical oxidation or reduction).
PEDOT:PSS is also substantially easier to process than vapour-phase poly-
merized PEDOT:TOS – both in terms of the time, effort, and equipment required
to fabricate thin films, as well as in terms of the (reproducible) quality of the
resulting films. A prime example of the latter is the strong sensitivity of the
VPP reaction to the ambient relative humidity. In the absence of a very well-
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controlled environment or closed system in which the PEDOT:TOS processing
can take place, the rate of the VPP reaction varies substantially from season to
season (and even day to day) as the humidity changes, and film quality varies
accordingly. Some level of humidity is required to catalyze the polymeriza-
tion reaction, and so during the dry winter months in Ithaca, water needs to be
added to the VPP chamber to simply enable the VPP reaction to proceed.
Additionally, it is insufficient to simply control the relative humidity within
the VPP chamber, as the preceding steps of spin coating and transferring the
sample into the VPP chamber provide opportunities for airborne moisture to
affect film properties. In particular, we observed small crystallites or domains
(∼5µm) in PEDOT:TOS films processed in humid conditions. These crystallites
have been shown to reduce the conductivity of the resulting film [130]. We hy-
pothesized the source of these domains to be water-induced crystallization that
likely occurred during the spin-coating step (as evidenced by the typically radial
orientation of the domains). This effect can be somewhat mitigated (although
not entirely prevented) with the addition of a high boiling-point solvent such as
PGMEA to the Fe(III):TOS precursor solution.
PEDOT:TOS does still hold the advantage over PEDOT:PSS of being able
to conformally coat architectures with non-line-of-sight structures (assuming
those structures can first be coated with the precursor solution); however, this
is perhaps the only remaining feature in its favour.
From a practical (and personal) standpoint, I have recently found it far more
reliable (and far less frustrating) to use PEDOT:PSS instead of PEDOT:TOS for
any applications that do not require thin conformal coatings (all 2-dimensional
applications for me thus far). While PEDOT:TOS was used for all of the early
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studies presented here [11, 35, 49], the final study (Progenitor Cell Adhesion and
Secretion, Chapter 5) was started on PEDOT:TOS, but ultimately completed on
PEDOT:PSS due to problems that arose with poor adhesion and poor electro-
chemical stability of the PEDOT:TOS films.
It is worth noting that the Malliaras group has had recent success with a dif-
ferent PEDOT:TOS protocol reported by Winther-Jensen [45], which uses a non-
hexahydrated Fe(III):TOS precursor, purchased in-solution. The resulting films
are reportedly more stable than those produced with the Fe(III):TOS hexahy-
drate salt. This new precursor solution is not widely available at present, but
can be purchased from some Chinese vendors (when it is in stock).
In the realm of fabricating conducting 3D architectures, PEDOT:TOS was
successful used to coat porous poly(lactic-co-glycolic acid) (PLGA) scaffolds
with a conductive PEDOT layer, while maintaining the desired open pore struc-
ture necessary for cell culture. In this endeavour, PEDOT:PSS may have been
less successful than PEDOT:TOS, in part due to its much higher viscosity as
compared to the Fe(III):TOS precursor solution, which might fill the pores of
the scaffold with excessive amounts of material.
However, with the development of the three-dimensional ice templating
technique (Chapter 6) to create 3D porous conducting scaffolds that support
cell culture very well, the need to coat PLGA scaffolds may now be obsolete.
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B.2 Adsorbing Fn Monolayers on PEDOT:TOS surfaces
We chose PEDOT:TOS as the electrochemically-active material on which to ad-
sorb proteins and culture cells. As described in Section 1.3.1, PEDOT is an elec-
trically and ionically conductive polymer, and shows excellent biocompatibil-
ity with a variety of cell types. Additionally, PEDOT’s tunable properties as a
function of electrochemical oxidation/reduction made it a strong candidate as
a substrate material for electrically-active cell culture.
B.2.1 PEDOT Thin-Film Device Fabrication
Devices (with either PEDOT:PSS or PEDOT:TOS) were fabricated on 1”×1” pat-
terned Indium Tin Oxide (ITO)-glass substrates (Kintec), or on bare glass sub-
strates as required. The ITO stripe was used to ensure the linearity of poten-
tial gradients, since conducting polymers change their conductivity upon ox-
idation/reduction (e.g., applying a potential gradient directly to a conducting
polymer film would result in a highly non-linear potential profile, with nearly
all of the potential dropped near the reducing electrode).
In device configurations that did not require a gradient (i.e., in the pixel de-
vice configuration), bare glass substrates (without ITO) were used to avoid two
complications: 1) the strong autofluorescence of ITO in the green wavelength
range (under 488nm excitation); and 2) the additional contact resistance be-




Substrates were cleaned according to a standard device-fabrication protocol:
They were first cleaned with regular laboratory detergent and water, and then
placed in a sonicator for 5 minutes each in subsequent solutions of deionized
(DI) water + detergent, followed by DI water. The substrates were then rinsed
in a DI water rinse tank under flow for 4 minutes.
Substrate patterning was accomplished throughout this work by masking
with the careful application of Scotch tape. Pattern sizes were typically on the
order of mm in size, so the use of more complex patterning techniques was un-
necessary. The typical pattern was a simple rectangular stripe, roughly 20mm
in width and 8mm in height. All of the above steps (cleaning and patterning)
were performed in a laminar flow hood to reduce surface contamination by air-
borne particles.
After cleaning and patterning, substrates were placed in a UV-Ozone cham-
ber for 15 minutes to strip any remaining organic surface contaminants, and
to decorate the substrate surfaces with -OH groups for better adhesion during
spin-coating. After this surface treatment, substrates were coated with either
PEDOT:PSS or PEDOT:TOS films, according to the following.
PEDOT:PSS Films
Device fabrication involved depositing and patterning PEDOT:PSS thin films
on glass substrates, and subsequently attaching polydimethylsiloxane (PDMS)
fluid reservoirs. 20mL of a PEDOT:PSS aqueous dispersion (Heraeus CleviosTM
PH 1000) was mixed with 5mL of ethylene glycol, 50µL of dodecylbenzenesul-
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fonic acid (DBSA), and 1 wt% of 3-glycidoxypropyltrimethoxysilane (GOPS, as
a cross-linker). The resulting dispersion was spin-coated on cleaned glass slides
(with tape lift-off masks to pattern the PEDOT:PSS) at 800 rpm for 60 seconds.
The films were subsequently baked at 140 ◦C for 1 hour, and then immersed in
phosphate buffered saline (PBS) for several hours to remove excess low molec-
ular weight compounds.
Fe(III):TOS Precursor/Oxidant Layer
PEDOT:TOS thin film fabrication consists of two steps: spin-coating a precursor
layer, followed by vapour-phase polymerization of PEDOT. The precursor solu-
tion consisted of 0.785g of Fe(III):TOS hexahydrate (Sigma Aldrich) dissolved
into 5mL of 2-propanol, with 32.1µL of anhydrous pyridine (Sigma Aldrich, as
a base inhibitor) and 500µL of propylene glycol methyl ether acetate (PGMEA,
Sigma Aldrich, as a high boiling point solvent). The inclusion of the PGMEA
was introduced to mitigate water-induced crystallization of the Fe(III):TOS film
during processing, which resulted in the presence of crystallites in the final PE-
DOT:TOS film.
The Fe(III):TOS precursor solution was spin-coated on the cleaned substrates
at 3000RPM for 60 s. The films were then baked on a hotplate at 140 ◦C for 120 s
to evaporate any remaining solvents.
Vapour-Phase Polymerization of PEDOT:TOS
PEDOT:TOS is polymerized by vapour-phase condensation of EDOT monomers
onto a thin film of an oxidizing species (Fe(III):TOS). The oxidant catalyzes the
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polymerization reaction, while a base inhibitor (pyridine) retards the rate of the
reaction to allow better film-formation.
The Fe(III):TOS-coated substrates were placed in a ReynoldsTech vapour-
phase polymerization (VPP) chamber. The substrates were heated to 35 ◦C and
a crucible containing EDOT monomer solution was heated to 80 ◦C (as deter-
mined by a conductivity optimization study). A membrane pump supplied a
vacuum of roughly 100 torr, and the substrates were left in the VPP chamber for
15 minutes.
After polymerization, the transparent yellow Fe(III):TOS films turn transpar-
ent blue, indicating the formation of PEDOT. Polymerized films were baked in
an oven at 50 ◦C for 1hour to allow the films to anneal. After cooling to room
temperature, the Scotch tape masks were removed from the substrates, and the
substrates were immersed in ethanol for 10 minutes, refreshing the solvent once
at 5 minutes, to dissolve remaining Fe salts.
For pixel configuration devices, a dividing line was scribed with a diamond
scribe vertically through the middle of the PEDOT (and ITO) stripe, separating
the stripe into two unconnected pixels.
Polydimethylsiloxane Reservoirs
Device fabrication is completed by attaching an appropriate fluid reservoir cut
from polydimethylsiloxane (PDMS). The PDMS (Sylgard 184) was cast at a ra-
tio of 10:1 base:cross-linker, and cured for 1h at 60 ◦C. Reservoirs were cut by
hand (razor blade and X-Acto knife), and placed in a UV-Ozone chamber for 10
minutes prior to being attached to the glass substrates.
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B.2.2 Adsorbing Fn Monolayers onto Devices
Fn Coating Solution
Fn was dissolved at a concentration of 30µg/ml in either cell culture media
(with or without serum) or in phosphate buffered saline (PBS), for coating de-
vices. In the case of FRET-labeled Fn (Fn-DA) devices, for measuring conforma-




FRET MEASUREMENTS AND ANALYSIS
C.1 Measuring Protein Conformation via FRET
The molecular conformation of surface-adsorbed Fn is assessed via the “molec-
ular ruler” mechanism provided by FRET, as described in Section 1.5.1. Ex-
perimentally, this measurement was performed on a (Zeiss LSM 710) confo-
cal microscope, capable of exciting the donor fluorophore via a 488nm Argon
laser while simultaneously measuring the total emission intensity of the donor
and acceptor fluorophores in their respective wavelength windows (∆λDon =
514 − 526nm, ∆λAcc = 566 − 578nm).
Images were acquired through a 25× water-immersion objective in 16-bit
colour depth (necessary for the low-intensity signal from a monolayer of pro-
tein), at a size of 512 × 512 px2 (340 × 340 µm2) and a pixel dwell-time of
2.55µm/px.
FRET ratio (IAcceptor/IDonor) was calculated for each field of view by integrating









|IFn − IControl| dλ, and
FRET = IAcceptor/IDonor.
Analysis was performed in MATLAB, with details outlined in Section C.1.1.
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C.1.1 Notes on FRET Analysis
Confocal microscope images were acquired in 16-bit colour (greyscale) depth, at
512×512 px resolution, in a two-channel stack. The two channels were exported
into individual 16-bit TIFF images via Zeiss’ Zen Software, which were then
read directly into MATLAB for analysis.
Briefly, a FRET map was generated for each donor-acceptor image pair by
pixel-wise division of the acceptor image by the donor image (after application
of a smoothing filter and omission of clipping pixels). This FRET image could
then be colourized with a heat map for visualization, and analyzed quantita-
tively with respect to the values of the FRET pixels. Typical quantities that were
calculated included: the mean, mode, and standard deviation of the FRET dis-
tribution (histogram). Further details of the analysis method and the source
code are contained in Section C.2 of Appendix C.
C.1.2 Potential Sources of Error in FRET Measurements
There are a variety of potential sources of error in the FRET measurements de-
scribed above, originating from both the device architecture itself, as well as
from the instrument used to measure the FRET signal. The sources of error
encountered in this work are outlined below, along with the strategies used to
account for them.
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Autofluorescence and background signal from ITO/PEDOT:TOS
The 100nm thick indium tin oxide layer in the device sandwich was found to
autofluoresce strongly in the green wavelength range, under excitation from a
488nm laser. This presents a significant challenge when measuring the FRET
signal (or any fluorescent signal) from single monolayers of adsorbed Fn, as the
(background) autofluorescence signal intensity is significantly stronger than the
fluorescent emission from either the donor or acceptor fluorophores.
Thankfully, since the ITO layer is separated from the Fn-DA by a 100nm-
thick PEDOT film, there is no concern of FRET (energy transfer) occurring be-
tween the ITO and the acceptor fluorophores. Thus, only the background aut-
ofluorescence signal from the ITO must be accounted for.
Ideally, this problem can be avoided entirely by not using ITO in the de-
vice architecture, or by replacing it with a non-fluorescent conductor. Avoiding
the use of the ITO film is possible in the pixel device configuration, however
it is necessary in the gradient device configuration in order to ensure the lin-
earity of the voltage gradient. It may be possible to replace the ITO with a
non-fluorescent transparent conductor in this configuration (i.e., a thin Au film),
however this was not tried.
To measure the autoflourescent signal for background subtraction, a mod-
ified device configuration was used, with two adjacent PDMS wells that both
spanned the width of the gradient device. One well was filled with Fn-DA in
PBS, while the other was filled with just PBS. The PBS-only well served as a
control to from which the autofluorescent emission of the ITO was measured as
a function of voltage with lambda scans. These background emission spectra
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were then subtracted from the full emission spectra measured from the Fn-DA
well to give the true FRET signal from the fluorophores.
Differential energy transfer from fluorophores to PEDOT:TOS
PEDOT:TOS is an optoelectronically active material, with an absorbance spec-
trum that varies with its redox state (the origin of its electrochromic behaviour).
This raises the concern that the donor and acceptor fluorophores could indi-
vidually (and differentially) transfer energy to the underlying PEDOT layer in
a parasitic FRET process (fluorescence quenching [131]) that would affect the
measured FRET intensity ratio.
By considering the PEDOT thin-film absorbance spectrum as a function of
redox voltage [132], we can show that the effect is minimal and has very little
effect on the overall FRET trend we observed. As shown in Figure C.1, such ad-
ditional energy transfer (if any) would be restricted to potentials ranging from
−0.65V to −1V, i.e., when PEDOT is slightly absorbing in our wavelength range
of interest (see Figure C.1). This would therefore have very little effect on our
FRET trend, which shows the greatest variation (FRET decrease) occurring from
1V to 0V, i.e., when PEDOT is not absorbing, while it is roughly constant from
0V to −1V.
Photomultiplier Tube (PMT) Detector Sensitivity
The Zeiss LSM 710 Confocal Microscope used to measure FRET has two photo-
multiplier tubes (PMTs) for simultaneous detection of donor and acceptor emis-
sions. To achieve simultaneous imaging, a beam-splitter is used to split the
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Figure C.1: Absorbance and emission spectra of Donor and Acceptor fluo-
rophores (coloured, dashed lines), overlayed with absorbance
spectra of PEDOT at various potentials (from [132]). The green
and red rectangles represent the donor and acceptor wave-
length windows used to calculate FRET. [11]
incoming light to the two PMTs. Either a difference in PMT sensitivity, or a de-
viation from a 50/50 split in the beamsplitter, would result in an artifact in the
measured FRET ratio. One or both of these may occur, but for the purposes of
this study only the total effect is important, and not what its origins are.
This effect is measured fairly easily by measuring the emission from single-
labelled Fn molecules, in solution (to avoid photobleaching), successively in
PMT1 and PMT2. By repeating this measurement for both the donor and ac-
ceptor fluorophores, the difference in PMT sensitivity (or beam-splitter uneven-
ness) is easily measured for a given wavelength range and a given objective lens.
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This artificial change in measured FRET ratio can then be normalized out of the
FRET ratio calculations with a simple multiplicative factor. At present (August
2012), PMT2 (the acceptor channel) is more sensitive than PMT1 (the donor chan-
nel) by a factor of roughly 2.2−2.4; however, repairs were performed on one (or
both) of the microscope’s PMTs since my last calibration, so this value may have
changed since then.
It should be noted that the Zeiss software does not allow (for some inexpli-
cable reason) for the obvious calibration measurement: to measure FRET from
the Donor (Acceptor) fluorophore with PMT1 (PMT2), followed by a reverse
measurement of the Acceptor (Donor) fluorophore with PMT1 (PMT2). Addi-
tionally, it is prudent to make the calibration measurements described above on
a semi-frequent basis (or even during every FRET imaging session), to ensure
that internal drift or changes to the microscope setup (due to maintenance, etc.)
have not altered the effective PMT sensitivity ratio.
C.2 FRET Analysis in MATLAB
The following code was modified from Delphine Gourdon’s BSFRET V17.m mat-
lab program to batch-process large numbers of FRET images.
1 function BSFRETv17_alwin_fullTIFFs
2 % ;..;d HARRO WORLD!
3
4 pmt_ratio = 2.7; % Intensity Ratio of PMT2/PMT1 (Acc/Don)
5 use_time_dependent_pmt_ratio = 0;
6 globalThresh = 70;
7 upper_thresh = 65530; % Upper intensity threshold to discard data
8




11 mkdir ./dat; % Output directory for data files
12
13 fileindex = dir('PBS_PLG*tif');
14 % filename_base = ...
fileindex(1).name(1:findstr(fileindex(1).name,'.')-4); % ...
Base name of first file
15 % t0_fileindex = dir(['../' filename_base '.lsm']); ...
% Corresponding LSM file
16 % t0 = datenum(t0_fileindex(1).date) * 24 * 60; ...
% t0 timestamp of LSM file
17
18 meanir = zeros(1,length(fileindex));
19 maxdo = meanir;
20 maxac = meanir;
21 meanac = meanir;
22
23 % DC and Threshold constants
24 dc1 = 0; dcSD1 = 0;
25 dc2 = 0; dcSD2 = 0;
26
27 accThresh = globalThresh; donThresh = globalThresh;
28 upLimit = 1.1; lowLimit = 0.3;




33 %number of bins in ir histogram
34 z = 90; binsize = (upLimit-lowLimit)/z;
35 %percentage data below ??M input
36 M0 = 1.02; M1 = 0.76; M2 = 0.68; M4 = 0.54;
37
38 % dc_LSMfiles = dir(['../_dc_*.lsm']);
39 % t0 = datenum(dc_LSMfiles(1).date) * 24 * 60;
40
41 for filecount = 1:(length(fileindex))
42 tif_file = fileindex(filecount).name;
43 tif_data = imread(tif_file); % ACC, DON, and blank channels
44 ac1 = tif_data(:,:,1); % ACCEPTOR
45 do1 = tif_data(:,:,2); % DONOR
46
47 filename_base = tif_file(1:findstr(tif_file,'.')-1); % ...
Remove filename suffix
48 %filename_base = ...
filename_base(findstr(tif_file,'_')+1:end); % Remove ...
filename prefix
49
50 %convert to double precision
51 ac1 = double(ac1); do1 = double(do1);
52
53 %averaging mask




56 %Remove dark current offset
57 ac1 = ac1 - (dc1 + 3*dcSD1); do1 = do1 - (dc2 + 3*dcSD2);
58
59 %compensate VPMT1=650V instead of 600V
60 %ac1 = ac1*600/650;
61
62 %compensate for 50_50BS intensity attenuation
63 if use_time_dependent_pmt_ratio % use fit equation for ...
DC data
64 curr_LSMfile = dir(['./' filename_base '.lsm']);
65 t = datenum(curr_LSMfile(1).date) * 24 * 60;
66 dt = t-t0;
67 pmt_ratio = (9.8e-011*dtˆ5 - 1.2e-008*dtˆ4 - ...
5.8e-008*dtˆ3 + 6.6e-005*dtˆ2 - 0.0033*dt + 0.55)*1.2;
68 end
69 do1 = do1*pmt_ratio;
70
71 %eliminate dim pixels
72 for x = 1:size(ac1,1)
73 for y = 1:size(ac1,2)
74 if ac1(x,y) ≤ accThresh || do1(x,y) ≤ ...
donThresh*pmt_ratio || ac1(x,y) ≥ upper_thresh ...
|| do1(x,y) ≥ upper_thresh






81 ir = ac1./do1;
82 ac_mean = mean(ac1(:)); ac_std = std(ac1(:));
83 do_mean = mean(do1(:)); do_std = std(do1(:));
84
85 %Convert matrix to image and save to disk
86 limits = [lowLimit upLimit];
87 irImage = mat2gray(ir, limits);
88




92 %Remove un-realistic ir values and NaNs
93 M0count = 0; M1count = 0; M2count = 0; M4count = 0;
94 for xx = 1:size(ir,1)
95 for yy = 1:size(ir,2)
96 if isnan(ir(xx,yy)) || ir(xx,yy) ≤ lowLimit || ...
ir(xx,yy) ≥ upLimit
97 ir(xx,yy) = 0;
98 end
99 if ir(xx,yy) ≤ M4 && ir(xx,yy) > 0
100 M4count = M4count + 1;
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101 end
102 if ir(xx,yy) ≤ M0 && ir(xx,yy) > 0
103 M0count = M0count + 1;
104 end
105 if ir(xx,yy) ≤ M2 && ir(xx,yy) > 0
106 M2count = M2count + 1;
107 end
108 if ir(xx,yy) ≤ M1 && ir(xx,yy) > 0










119 percentbelowM2 = M2count/(avgirsize(1,1))*100;
120 percentbelowM1 = M1count/(avgirsize(1,1))*100;
121 percentbelowM4 = M4count/(avgirsize(1,1))*100;
122 percentbelowM0 = M0count/(avgirsize(1,1))*100;
123 per5 = prctile(avgirArray,5);
124 per95 = prctile(avgirArray,95);
125
126 %generate a histogram for ir mode determination and display
127 bins = lowLimit:binsize:upLimit;
128 [histCounts, histX] = hist(avgirArray,bins);
129 [C,I] = max(histCounts);
130 modeReal = histX(I); %Calculate mode from histogram data




134 subplot(3,1,[1 2]); imagesc(ir, limits);
135 axis off; axis square;
136 colorbar('horiz');
137 set(gca, 'FontName', 'Times New Roman', 'FontSize', 12);
138 subplot(3, 1, [3]); bar(histX, histCounts);
139 xlabel('intensity ratio (acceptor/donor)', 'FontName', ...
'Times New Roman', 'FontSize', 12);
140 ylabel('events', 'FontName', 'Times New Roman', 'FontSize', ...
12);
141 set(gca, 'FontName', 'Times New Roman', 'FontSize', 12);
142 axis([lowLimit upLimit 0 1]);
143
144 %save the final data as a .tiff
145 saveas(figure(1), strcat('./t',num2str(accThresh),'/', ...
filename_base,'_fig'), 'tif');
146
147 %output data for further analysis into a text file
148 output = [ avgirmean modeReal avgirstd avgirsize(1,1) ...
130
percentbelowM4 percentbelowM2 percentbelowM1 ...
percentbelowM0 per5 per95 ac_mean ac_std do_mean do_std ...
pmt_ratio];
149 out_filename = strcat('./dat/',filename_base, '_data.out');
150 save(out_filename, 'output', '-ASCII', '-tabs');
151 %output histogram data
152 output = [ histX' histCounts' ];
153 out_filename = strcat('./dat/',filename_base, '.hist');
154 save(out_filename, 'output', '-ASCII', '-tabs');
155
156 fprintf('%s ...\t\t(%d/%d)\n', tif_file, filecount, ...
length(fileindex));
157 meanir(filecount) = avgirmean;
158 maxdo(filecount) = max(do1(:));
159 maxac(filecount) = max(ac1(:));




164 fprintf('avg IR = %.3g +/- %.3g\n', mean(meanir), std(meanir));
165 fprintf('max DO = %.3g +/- %.3g\n', mean(maxdo), std(maxdo));
166 fprintf('max AC = %.3g +/- %.3g\n', mean(maxac), std(maxac));
167 fprintf('avg AC = %.3g +/- %.3g\n', mean(meanac), std(meanac));
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APPENDIX D
NEAR EDGE X-RAY ABSORPTION FINE STRUCTURE (NEXAFS)
D.1 Characterization of PEDOT:PSS Films
Oxidized (+1V) and reduced (−1V) PEDOT:PSS thin films were prepared and
and scanned by Carol Newby at the Brookhaven National Laboratory syn-
chrotron. The goal was to attempt to characterize the chemical changes that
take place under electrochemical oxidation/reduction in the PEDOT:PSS films.
Both carbon and oxygen peaks were recorded. While the carbon peaks showed
no differences for the oxidized and reduced samples, differences were observed
in the oxygen peaks, as shown in Figure D.1. No angular dependence was ob-
served for either condition.
Further interpretation of these results is required, and additional scans (per-
haps of the sulfur peaks) could yield useful information about the surface chem-
istry.
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Figure D.1: Oxygen peaks measured by NEXAFS from an oxidized and a
reduced PEDOT:PSS film, at an incident angle of 60°.
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